Download Wednesday September 12, 2012

CARO 2012 – Targeting Biology
September 12-15, 2012
Ottawa Convention Centre – 55 promenade du Colonel
DRAFT: June 17, 2012
Wednesday September 12, 2012
Resident Refresher Course
Room 205
Facilitator: Shahida Ahmed
Objectives:
7:00-8:00
Registration and Breakfast
8:00-8:10
Welcome
8:10- 8:50
CNS Malignancies
Glenn Bauman
8:50-9:30
Skin Cases
Woodrow Wells
9:30-10:10
Esophagus / GE Junction
Wayne Kendal
10:10-10:30
Break
10:30-11:10
Head & Neck Cases
Khalil Sultanem
11:10-11:50
Lymphomas
Richard Tsang
11:50-1:00
Lunch
1:00-2:00
Keynote Address: Drug-Radiotherapy Interactions to Improve Cure:
Present and Future
Kevin Camphausen
2:00-2:40
Ca Cervix
Choan E
2:40-3:00
Break
3:00-4:30
Career Counseling
Department Heads
4:30-4:40
Closing Remarks & Evaluations
Molecular Targeted Therapies Integrated Into Radiation Oncology Preconference
Room 207
Facilitators: Robert Bristow, Thierry Muanza
Objectives: At the end of this CARO Pre-Conference, the attendees should be able to:
• describe the interactions of molecular targeted agents and radiotherapy
• describe the relevant biomarkers for efficacy and toxicity of molecular combined modality
therapy
• apply these concepts to cases commonly presenting in radiotherapy clinics
• understand the use of genomic and proteomic discovery approaches in biomarker
development for oncologic use
7:30-8:00
Registration and Breakfast
8:00-8:10
Welcome and Introduction
Robert Bristow
8:10-9:10
Keynote Address: Design and Conduct of Trials Combining Radiotherapy
and Targeted Therapeutics
Anne Hansen Ree
9:10-9:25
Head and Neck and Central Nervous System Cancers
Key Questions and Illustrative
Moderators: Fei-Fei Liu, Thierry Muanza
9:25-10:05
Abstracts - HEENT and CNS
9:25-9:35
1
ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS AND
LATE SALIVARY GLAND TOXICITY FOLLOWING INTENSITY
MODULATED RADIOTHERAPY (IMRT)
1
1
2
1
Lisa Capelle , Sunita Ghosh , Sana Vahidy , Brad Warkentin , Rufus
1
1
1
1
Scrimger , Naresh Jha , David Murray , Matthew Parliament
1
2
Cross Cancer Institute, Edmonton, AB; University of Alberta,
Edmonton, AB
9:35-9:45
2
NOVEL ROLE OF 06-METHYLGUANINE METHYLTRANSFERASE
(MGMT) IN GLIOBLASTOMA ANGIOGENESIS AND INVASION:
BIOLOGICAL AND CLINICAL SIGNIFICANCE
1
2
1
Bassam Abdulkarim , Manik Chahal , Yaoxian Xu , Marie-Christine
1
3
1
Guiot , Jaw Easaw , Siham Sabri
1
2
McGill University, Montreal, QC; University of Alberta, Edmonton, AB;
3
University of Calgary, Calgary, AB
9:45-9:55
3
DOES DOXYCYCLINE TREATMENT OF EPIDERMAL GROWTH
FACTOR RECEPTOR (EGFR) INHIBITOR RASH ALSO HAVE AN
ANTI-TUMOUR EFFECT? PRELIMINARY EVIDENCE FROM CELL
CULTURE STUDIES
David Palma, Peter Ferguson, Rene Figueredo, Anthony Nicolas, Eric
Winquist, Scott Ernst, James Koropatrick
London Regional Cancer Program, London, ON
9:55-10:10
4
IRRADIATION OF THE BRAIN OF FISHER RAT PROMOTES
MIGRATION OF GLIOMA CELL F98 AND DECREASES THE LIFE
EXPECTANCY OF ANIMALS
Benoit Paquette, Guillaume Desmarais, David Fortin, David Mathieu
Université de Sherbrooke, Sherbrooke, QC
10:05-10:25
Break
10:25-10:40
Lung and Breast Cancer
Key Questions and Illustrative Case
Moderators: Theodoros Tsakiridis, Bassam Abdulkarim
10:40-11:20
Abstracts – Lung and Breast
10:40-10:50
5
TIME AND SEQUENCE DEPENDENCY OF SORAFENIB IN
COMBINATION WITH IONIZING RADIATION IN METASTATIC
BREAST CANCER MODEL
Mitra Heravi, Thierry Muanza, Danuta Radzioch
McGill University, Montreal, QC, Canada
10:50-11:00
6
ULTRASOUND AND MICROBUBBLES MEDIATED ENHANCEMENT
OF GOLD NANOPARTICLES WITH RADIOTHERAPY IN BREAST
CANCER: IN VITRO STUDY
1
2
2
Amanda Thu Lee Tran , Gregory J. Czarnota , Jean-Philippe Pignol ,
1
Raffi Karshafian
1
2
Ryerson University, Toronto, ON; Sunnybrook Health Sciences Centre,
Toronto, ON
11:00-11:10
7
SESTRIN2 SENSITIZES BREAST AND LUNG CANCER CELLS TO
IONIZING RADIATION THROUGH MODULATION OF AMPACTIVATED PROTEIN KINASE (AMPK)
Toran Sanli, Katja Linher-Melville, Yaryna Storozhuk, Gurmit Singh,
Theodoros Tsakiridis
McMaster University, Hamilton, ON
11:10-11:20
8
PRE-IRRADIATION OF THE MAMMARY GLAND IN MICE INCREASES
THE INVASIVENESS OF BREAST CANCER CELLS AND LUNG
METASTASES
Benoit Paquette, Gina Bouchard, Caroline Saucier
Université de Sherbrooke, Sherbrooke, QC
11:20-11:35
Genomic Approaches to Biomarkers
Robert Bristow
11:35-12:05
Abstracts – Biomarkers
11:35-11:45
9
DICENTRIC CHROMOSOME ASSAY: A POTENTIAL BIOMARKER
FOR RADIOSENSITIVITY
1
2
1
1
Sara Samiee , Lindsay Beaton , Scott Grimes , Christina Addison , Libni
1
1
3
1
1
Eapen , Choan E , Kyle Malone , Ruth Wilkins , Shawn Malone
1
2
3
University of Ottawa, Ottawa, ON; Health Canada, Ottawa, ON; The
Ottawa Hospital, Ottawa, ON
11:45-11:55
10
THE EFFECTS OF FRACTIONATED RADIOTHERAPY ON
LYMPHOCYTE RADIATION RESPONSE
Kara Schnarr, Ian Dayes, Douglas Boreham
McMaster University, Hamilton, ON
11:55-12:05
11
CAN FDG PET DURING THE COURSE OF RADIATION THERAPY
FOR LUNG CANCER PREDICT FOR ESOPHAGITIS AND
PNEUMONITIS
Paula McCloskey, Victoria Ford, Nathan Becker, Jean-Pierre
Bissonnette, Katy Clarke, Jane Higgins, Claudia Leavens, Andrew Hope,
Andrea Bezjak, Alexander Sun
Princess Margaret Hospital, Toronto, ON
12:05-1:00
Lunch
1:00-2:00
Keynote Address: Drug-Radiotherapy Interactions to Improve Cure:
Present and Future
Kevin Camphausen
2:00-2:15
Gynecologic, Genitorurinary and Gastrointestinal Tumours
Key Questions and Illustrative Case
Moderators: Stanley Liu, Te Vuong
2:15-2:45
Abstracts – Gynae, GI and GU
2:15-2:25
12
ULTRASOUND-MICROBUBBLES COMBINED WITH CHEMOTHERAPY
ENHANCED RESPONSE OF IONIZING RADIATION IN PROSTATE
CANCER CELLS
1
2
2
1
Firas Almasri , Gregory J. Czarnota , Shun Wong , Raffi Karshafian
1
2
Ryerson University, Toronto, ON; Sunnybrook Health Sciences Centre,
Toronto, ON
2:25-2:35
13
DNA PLOIDY BASED ON ARCHIVED BIOPSY MATERIAL MAY
CORRELATE WITH PSA RECURRENCE AFTER PROSTATE
BRACHYTHERAPY
1
2
3
Mira Keyes , Calum MacAulay , Malcolm Hayes Hayes , Jagoda
2
2
1
2
Korbelik , Dave Garner , W. James Morris , Branko Palcic
1
2
British Columbia Cancer Agency, Vancouver, BC; British Columbia
3
Cancer Research Centre, Vancouver, BC, University of British
Columbia, Vancouver, BC
2:35-2:45
14
TARGETED TREATMENT WITH ANTI-EGFR ANTIBODIES AND
RADIATION THERAPY FOR PATIENTS WITH SQUAMOUS CELL
CARCINOMA OF THE ANAL CANAL: RATIONALE OF STUDY
PROPOSAL
1
1
2
3
Té Vuong , Tamim Niazi , Aleksandra Paliga , Francois Coutlee , Ronald
4
5
1
1
Onerheim , George Chong , Alex Ferenczy , Adrian Gologan , Marc
6
7
3
1
Steben , Alexandra De Pokomandy , Bernard Trottier , Gerald Batist
1
2
Jewish General Hospital, Montréal, QC; University of Ottawa, Ottawa,
3
4
ON; CHUM, Montreal, QC; Saint-Mary's Hospital, Montreal, QC;
5
6
7
McGill University, Montreal, QC; La Clinique A, Montreal, QC, Institut
Thoracique de Montreal, Montreal, QC
2:45-3:15
Break
3:15-5:00
Combined Modality Therapy Workshop
Novel Radiomodifiers: From Concept to Clinical Trial Design
Bassam Abdulkarim, Theo Tsakiridis
5:00-5:15
Close and Evaluation
Robert Bristow
Thursday September 13, 2012
7:00-8:00
Breakfast and Registration
Level 2
8:00-8:20
Welcome and Presidential Address
Room 205-208
Lava Grimard
Andrea Bezjak
8:20-9:20
CARO Lecture
Introduction: Guila Delouya
Changing Demographics of Head and Neck Carcinoma
Kian Ang
9:20-11:00
Resident Competition
Moderator: Kian Ang
Objectives:
To review Canadian Radiation Oncology Resident Research Projects.
9:20-9:30
15
PROSPECTIVE SWALLOWING OUTCOMES AFTER INTENSITY
MODULATED RADIOTHERAPY FOR OROPHARYNGEAL CANCER:
DOSIMETRIC CORRELATIONS IN A POPULATION BASED COHORT
Gordon Guo, Candace Myers, Keith Sutherland, Pascal Lambert, Jim
Butler, Ahmet Leylek, Harvey Quon
University of Manitoba, Winnipeg, MB
9:30-9:40
16
SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) ASSOCIATED
WITH LATE RADIATION RECTAL TOXICITY AFTER PROSTATE
BRACHYTHERAPY
Nelson Leong, Matthew Parliament, Kevin Martell, Sunita Ghosh,
Nadeem Pervez, John Pedersen, Don Yee, Albert Murtha, John Amanie
University of Alberta, Edmonton, AB
9:40-9:50
17
RADIOGRAPHIC CHANGES AFTER LUNG STEREOTACTIC
ABLATIVE RADIOTHERAPY (SABR) – CAN WE DISTINGUISH
RECURRENCE FROM FIBROSIS? A SYSTEMATIC REVIEW OF THE
LITERATURE
1
2
2
3
Kitty Huang , Max Dahele , Suresh Senan , Matthias Guckenberger ,
1
4
4
1
George Rodrigues , Aaron Ward , Gabriel Boldt , Daivd Palma
1
2
London Health Sciences Centre, London, ON; VU University Medical
3
Center, Amsterdam, Netherlands; University Hospital of Wuerzburg,
4
Wuerzburg, Germany; University of Western Ontario, London, ON
9:50-10:00
18
PELVIC BONE MARROW DOSIMETRIC PARAMETERS AND
ASSOCIATED HEMATOLOGIC TOXICITY IN ANAL CANCER
PATIENTS TREATED WITH CONCURRENT CHEMORADIATION: A
COMPARISON OF 3D-CONFORMAL AND INTENSITY MODULATED
RADIOTHERAPY TECHNIQUES
1
1
1
2
Fleure Gallant , Slobodan Devic , Tamin Niazi , Kamran Kafi , Aurelie
1
1
1
1
1
Garant , Isabelle Lavoie , Christina Holcroft , Te Vuong , Fleure Gallant
1
2
Jewish General Hospital, Montreal, QC; McGill University, Montreal,
QC
10:00-10:10
19
MULTIDISCIPLINARY ASSESSMENT AND REPORTING OF FITNESS
TO DRIVE IN BRAIN TUMOUR PATIENTS: A GRAY MATTER
1
2
1
1
Alexander Louie , Esther Chan , Michelle Hanna , David Palma , Glenn
1
1
1
1
Bauman , Barbara Fisher , George Rodrigues , Abhinay Sathya , David
1
D'Souza
1
2
London Regional Cancer Program, London, ON; University of Western
Ontario, London, ON
10:10-10:20
20
UTILIZATION OF PREOPERATIVE RADIOTHERAPY FOR RECTAL
CANCER PATIENTS IN MANITOBA: A POPULATION-BASED
ANALYSIS
Benjamin Mou, Andrew L. Cooke, Lin Xue
CancerCare Manitoba, Winnipeg, MB
10:10-10:20
21
USE OF PROTOPORPHYRIN FLUORESCENCE TO DETERMINE
CLINICAL TARGET VOLUME MARGINS FOR NON-MELANOTIC SKIN
CANCERS TREATED WITH PRIMARY RADIOTHERAPY
1
2
2
2
1
Lara Best , Olga Vujovic , Kevin Jordan , Barbara Fisher , Deb Carey ,
1
2
Deborah Bourdeau , Edward Yu
1
2
London Regional Cancer Program, London, ON; University of Western
Ontario, London, ON
10:30-10:40
22
IMPROVING TARGET COVERAGE FOR POST-OPERATIVE
1
2
PROSTATE CANCER PATIENTS Jennifer Croke , Balazs Nyiri , Yan
2
2
2
2
2
Li , Len Avruch , Eric Belanger , Chris Morash , Cathleen Kayser , Kyle
2
2
Malone , Shawn Malone
1
2
University of Ottawa, Ottawa, ON; The Ottawa Hospital, Ottawa, ON
10:40-10:50
23
PREDICTORS OF PROSTATE BED CONTOURING VARIABILITY: AN
INTERNATIONAL CONTOURING CHALLENGE
1
1
2
Vikram Velker , Alexander Louie , Jay Markham
1
2
London Regional Cancer Program, London, ON; Radiation Oncology
Resources, Goshen, IN
10:50-11:00
24
MORE RADIATION ONCOLOGISTS TRANSLATES TO MORE
CANCER PATIENTS RECEIVING MORE TIMELY TREATMENT
1
1
1
1
Inge Aivas , Vusal Babashov , Mehmet Begen , Greg Zaric , Jeffrey
2
1
1
1
Cao , Derrick Fournier , David D'Souza , George Rodrigues , Michael
1
Lock
1
2
University of Western Ontario, London, ON; University of British
Columbia, Vancouver, BC
11:00-11:30
Break
11:30-12:40
Theme Symposium – Debate
Moderators: Robert Bristow, Thierry Muanza
This house believes molecular targeted drugs and radiation therapy
supplant standard chemotherapy and radiation therapy in head and neck
cancer.
Debaters: Kian Ang, Kevin Camphausen, tba
12:30-2:30
Lunch – on your own
Industry Symposium – Elekta Room 209
Committee Meetings
2:30-3:30
Poster Preview 1 - Abstract # 25-74
Moderator: Christina Parsons, Tara Roswell
25
DOES THE STAGING OF CERVICAL CANCER PATIENTS, TREATED
WITH CHEMORADIATION, BY LYMPHADENECTOMY, PET, OR MRI
HAVE A SURVIVAL IMPACT?
1
2
3
3
Joanne Alfieri , Thomas Jobling , Kailash Narayan , David Bernshaw ,
4
Srinivas Kondalsamy-Chennakesavan
1
2
McGill University Health Centre, Montreal, QC; Monash University,
3
Melbourne, Victoria, Australia; University of Melbourne, Melbourne,
4
Victoria, Australia; Royal Brisbane and Women's Hospital, Herston,
Queensland, Australia
26
HUMAN PAPILLOMA VIRUS, P16 AND P53 STATUS IN PATIENTS
WITH VULVAR SQUAMOUS CELL CARCINOMA TREATED WITH
RADIOTHERAPY
Julie Cuartero, Ghassan Allo, Mei Ling Yap, Melania Pintilie, Anthony
Fyles, Joan Murphy, Helen Mackay, Suzanne Kamel-Reid, Michael
Milosevic, Blaise Clarke
Princess Margaret Hospital, Toronto, ON
27
ELECTIVE RADIOTHERAPY TO PARA-AORTIC LYMPH NODES IN
MANAGEMENT OF CERVIX CARCINOMA WITH CONCURRENT
CHEMO-RADIOTHERAPY
Julie Cuartero, Mei Ling Yap, Jing Yan, Melania Pintilie, Krisha
Opfermann, Wilfred Levin, Lee Manchul, Michael Milosevic, Anthony
Fyles
Princess Margaret Hospital, Toronto, ON
28
TREATMENT OUTCOMES OF STAGE IIIC ENDOMETRIAL CANCER
TREATED WITH PELVIC OR EXTENDED FIELD IRRADIATION
1
1
1
Caroline Holloway , Cheryl Alexander , Caroline Walter , Christina
2
1
Aquino-Parsons , Pauline Truong
1
British Columbia Cancer Agency, Vancouver Island Centre, Victoria,
2
BC; British Columbia Cancer Agency, Vancouver Centre, Vancouver,
BC
29
STEREOTACTIC BODY RADIOTHERAPY IN CASES UNSUITABLE
FOR GYNECOLOGICAL BRACHYTHERAPY
Nikhilesh Patil, George Hajdok, Brian Yaremko, Kathleen Surry, Michel
Prefontaine, Akira Sugimoto, David D'Souza
University of Western Ontario, London, ON
30
CLINICAL IMPLEMENTATION OF POST-OPERATIVE GYNECOLOGIC
IMRT WITH SINGLE CT SIMULATION: DOSIMETRIC ADVANTAGES
COMPARED TO 3D-CONFORMAL
Ericka Wiebe, Joe Presutti, Melanie Davidson, Kitty Yip, Ida Ackerman,
Toni Barnes, Gillian Thomas, Lisa Barbera
Odette Cancer Centre, Toronto, ON
31
ACCUMULATED VERSUS PLANNED DOSIMETRY IN PULSED DOSE
RATE (PDR) BRACHYTHERAPY FOR CERVICAL CARCINOMA
BASED ON SOFT TISSUE DEFORMATION ANALYSIS
Mei Ling Yap, Julie Cuartero, Seungjong Oh, Young-bin Cho, Marita
Morgia, Xie Jason, Levin Wilfred, Lee Manchul, Anthony Fyles, Michael
Milosevic
Princess Margaret Hospital, Toronto, ON
32
DOSE CONFORMALITY AND ACUTE TOXICITY ANALYSIS IN
PATIENTS WITH PROSTATE ADENOCARCINOMA TREATED WITH
VOLUMETRIC MODULATED ARC THERAPY (VMAT) VERSUS
CONVENTIONAL INTENSITY MODULATED RADIATION THERAPY
(IMRT)
David Cuthbert, Charles Catton, Patricia Lindsay, Haiyan Jiang, Robert
Bristow, Elantholi P Saibishkumar, Cynthia Menard, Lucy Lu, Andrew
Bayley
Princess Margaret Hospital, University of Toronto, Toronto, ON
33
ACUTE TOXICITY IN HIGH-RISK PROSTATE CANCER PATIENTS
TREATED WITH HYPOFRACTIONATED IMRT WITH SIMULTANEOUS
INTEGRATED BOOST
Magali Lecavalier-Barsoum, Sergio Faria, Russel Ruo, Fabio Cury, Marc
David, Marie Duclos, Luis Souhami
McGill University Health Centre, Montreal, QC
34
HYPOFRACTIONATED AND CONVENTIONALLY FRACTIONATED
RADIOTHERAPY SCHEDULES FOR LOCALIZED PROSTATE
CANCER
1
2
1
1
Gary Mok , Jarad Martin , Christine Massey , Andrew Bayley , Cynthia
1
1
1
1
Ménard , Peter Chung , Robert Bristow , Padraig Warde , Mary
1
1
Gospodarowicz , Charles Catton
1
2
Princess Margaret Hospital, Toronto, ON; Radiation Oncology
Queensland, Toowoomba, Queensland, Australia
35
RADIOTHERAPY AFTER RADICAL PROSTATECTOMY: TREATMENT
RECOMMENDATIONS DIFFER BETWEEN UROLOGISTS AND
RADIATION ONCOLOGISTS
1
1
2
1
Luke Lavallee , Scott Morgan , Dean Fergusson , Renee Grenon ,
2
1
1
1
Franco Momoli , Christopher Morash , Ilias Cagiannos , Rodney Breau
1
2
University of Ottawa, Ottawa, ON; Ottawa Hospital Research Institute,
Ottawa, ON
36
USE OF PRE-OP MRI AND '3D PROSTATE CANCER MAPS' TO
IMPROVE CTV DEFINITION FOR POST-OPERATIVE PROSTATE
RADIATION
1
2
1
1
Shawn Malone , Jennifer Croke , Eric Belanger , Kyle Malone , Len
1
2
1
1
1
Avruch , Colin Malone , Chris Morash , Yan Li , Balazs Nyiri
1
2
The Ottawa Hospital, Ottawa, ON; University of Ottawa, Ottawa, ON
37
LATE RESULTS OF PURE HYPOFRACTIONATION FOR PROSTATE
CANCER
1
2
3
2
Dilip Panjwani , Darin Gopaul , Omar Qazi , Pierre Fortin , Ramana
3
Rachakonda
1
2
British Columbia Cancer Agency, Vancouver, BC; University of
3
Western Ontario, Kitchener, ON; McMaster University, Hamilton, ON
38
PSA BOUNCE AFTER HDR PROSTATE BRACHYTHERAPY AND
HYPOFRACTIONATED EXTERNAL BEAM RADIOTHERAPY
Nita Patel, Fabio Cury, Luis Souhami, Armen Aprikian, Sergio Faria,
Marc David, Marie Duclos, McGill University Health Centre, Montreal, QC
39
THE IMPACT OF COMORBIDITIES ON THE BENEFITS OF
PROLONGED ANDROGEN ABLATION IN PATIENTS WITH T3-4
PROSTATE CANCER
Eric Tran, Matthew Paquette, Justin Jay, Mitchell Liu, Jeremy Hamm,
Graeme Duncan, Tom Pickles, Scott Tyldesley, British Columbia Cancer
Agency, Vancouver, BC
40
A RANDOMIZED TRIAL COMPARING SEED LOSS AND
DISPLACEMENT OF ANCHORSEEDS TO STANDARD UNCOATED
LOOSE SEEDS
1
2
2
2
David Bowes , Juanita Crook , Deidre Batchelar , Cynthia Araujo , Brent
2
2
2
2
Parker , David Kim , Miren Gaztanaga , Marie-Pierre Milette , Rasika
2
2
2
Rajapakshe , David Petrik , Ross Halperin
1
2
Nova Scotia Cancer Agency, Halifax, NS; British Columbia Cancer
Agency, Kelowna, BC
41
IMPACT OF TRANSRECTAL ULTRASOUND PROBE ON PROSTATE
POSITION AND DOSE DISTRIBUTION DURING PERMANENT SEED
IMPLANTATION
Amanda Cherpak, Joanna Cygler, Choan E, Gad Perry
The Ottawa Hospital Cancer Centre, Ottawa, ON
42
SPHINCTER CONDITIONING EXERCISES FOLLOWING
POSTPROSTATECTOMY RADIOTHERAPY
1
2
Libni Eapen , Ionut Busca
1
2
Ottawa Regional Cancer Centre, Ottawa, ON; University of Ottawa,
Ottawa, ON
43
FEASIBILITY, DETECTABILITY AND EXPERIENCE WITH PLATINUM
SEED INTERNAL FIDUCIAL MARKERS FOR CT-MRI FUSION AND
REAL-TIME TUMOUR TRACKING DURING STEREOTACTIC
ABLATIVE RADIOTHERAPY
Vimoj Janardanan Nair, Janos Szanto, Eric Vandervoort, Elizabeth
Henderson, Leonard Avruch, Shawn Malone, Jason Pantarotto
University of Ottawa, Ottawa, ON
44
LONG-TERM OUTCOMES OF RADIOTHERAPY FOR STAGE II
TESTICULAR SEMINOMA – MAYO CLINIC EXPERIENCE
Chunhee Richard Choo, Christopher Hallemeier
Mayo Clinic, Rochester, MN
45
RETROSPECTIVE REVIEW OF PATHOLOGY REPORTS OF
PATIENTS DIAGNOSED WITH PENILE CANCER OVER A PERIOD OF
10 YEARS IN ONTARIO
Darwin Yip, Aamer Mahmud
Queen's University, Kingston, ON
46
DOWNSIZING AND DOWNSTAGING OF LOCALLY ADVANCED
RECTAL CANCER AFTER SHORT COURSE RADIOTHERAPY (RT)
FOLLOWED BY DELAYED SURGERY
1
1
1
1
Sergio Faria , Neil Kopek , Tarek Hijal , Sender Liberman , Patrick
1
1
1
1
Charlebois , Barry Stein , Sarkis Meterissian , Ari Meguerditchian , Eric
2
3
Debroux , Donna Tataryn
1
2
McGill University, Montreal, QC; University of Montreal, Montreal, QC;
3
St Mary's Hospital, Montreal, QC
47
CLINICAL TARGET VOLUME DELINEATION OF LIVER TUMOURS ON
4D-CT, DYNAMIC CONTRAST ENHANCED CT AND PERFUSION CT
1
2
2
2
Nikolaj Jensen , Danielle Mulder , Michael Lock , Barbara Fisher ,
3
4
2
1
Roman Kozak , Ting-Yim Lee , Jeff Chen , Eugene Wong
2
1
University of Western Ontario, London, ON; London Regional Cancer
3
4
Program, London, ON; St. Josephs Health Care, London, ON; Robarts
Research Institute, London, ON
48
COMPARISON OF ADJUVANT CHEMORADIATION (MCDONALD)
AND PERI-OPERATIVE CHEMOTHEARPY (MAGIC) FOR THE
TREATMENT OF GASTRIC AND GASTROESOPHAGEAL JUNCTION
ADENOCARCINOMA
1
2
1
Haerin Kim , Devin Schellenberg , Christian Kollmannsberger , Winson
1
1
Cheung , Howard Lim
1
2
British Columbia Cancer Agency, Vancouver, BC; British Columbia
Cancer Agency, Surrey, BC
49
ONE VERSUS TWO CYCLES OF MITOMYCIN C IN CONCURRENT
CHEMORADIATION FOR TREATMENT OF ANAL CANAL
CARCINOMA: AN ANALYSIS OF OUTCOMES AND TOXICITY
1
1
1
1
Rosanna Yeung , Yarrow McConnell , George Roxin , Robyn Banerjee ,
1
1
1
Gloria B Roldán Urgoiti , Anthony R MacLean , W Donald Buie , Karen E
2
1
2
1
Mulder , Michael M Vickers , Kurian J Joseph , Corinne M Doll
1
2
University of Calgary, Calgary, AB; University of Alberta, Edmonton, AB
50
A PROSPECTIVE STUDY TO UNDERSTAND THE EARLY
HEMATOLOGICAL EFFECTS OF CHEMO-RADIATION THERAPY IN
CANCER PATIENTS AND THEIR PATTERN OF RECOVERY
Manpreet Tiwana, Hsueh Ni Lee, Manmohan Mahajan, Sheila Das,
Pamela Jeyaraj, Jaineet Sachdeva
Christian Medical College and Hospital, Ludhiana, India
51
EVALUATION OF LOCAL CONTROL AND RADIATION DOSE
RESPONSE FOR RADIATION THERAPY OF PRIMARY AND
METASTATIC LIVER CANCER
Anthony Lausch, Kevin Sinclair, Michael Lock, Barbara Fisher, Nikolaj
Jensen, Stewart Gaede, Jeff Chen, Eugene Wong
The University of Western Ontario, London, ON
52
OUTCOME OF STEREOTACTIC BODY RADIATION THERAPY FOR
PRIMARY HEPATOCELLULAR CARCINOMA PATIENTS: RESULTS
FROM TWO INSTITUTIONS
1
2
3
Melissa Azoulay , Neil Kopek , David Roberge
1
2
McGill University, Montreal, QC; McGIll University Health Centre,
3
Montreal, QC; Centre Hospitalier de l'Université de Montréal, Montreal,
QC
53
LATE SIDE EFFECTS OF PRE-OPERATIVE ENDORECTAL
BRACHYTHERAPY AND TOTAL MESORECTAL EXCISION IN
RECTAL CANCER PATIENTS
1
1
2
1
Daniel Bernad , Hani Al-Halabi , Tamim Niazi , Christina Holcroft , Diana
1
2
Mohid , Té Vuong
1
2
McGill University, Montreal, QC; Jewish General Hospital, Montreal,
QC
54
OUTCOMES FOR POST-SURGICAL HYPOFRACTIONATED
STEREOTACTIC CAVITY RADIOTHERAPY (HSCRT) AS SALVAGE
FOR PATIENTS WITH PRIOR WHOLE BRAIN RADIATION (WBRT) AS
COMPARED TO UPFRONT ADJUVANT HSCRT
Ameen Alomair, Hany Soliman, Wei Xu, Aliaksandr Karotki, Nicolas
Phan, Sunit Das, James Perry, May Tsao, Todd Mainprize, Arjun Sahgal,
University of Toronto, Toronto, ON
55
A POPULATION-BASED STUDY ON THE UPTAKE AND UTILIZATION
OF STEREOTACTIC RADIOSURGERY (SRS) FOR BRAIN
METASTASIS IN NOVA SCOTIA
Gaurav Bahl, Karl Tennessen, Ashraf Mahmoud-Ahmed, Dorianne
Rheaume, Ian Fleetwood, Liam Mulroy
Dalhousie University, Halifax, NS
56
INVESTIGATING POTENTIAL UTILITY OF A MOCK FOR FRAMELESS RADIOSURGERY FOR BRAIN METASTASES
Jon-Paul Voroney, Karen Breitman, Hudson Alana, Rao Khan, Harold
Lau, Lesiuk Mark, Gerald Lim, Chris Newcomb, Robert Nordal, David
Spencer
Tom Baker Cancer Centre, Calgary, AB
57
INCIDENCE OF PAIN FLARE FOLLOWING STEREOTACTIC BODY
RADIOTHERAPY FOR BONE METASTASES
Andrew Chiang, Liang Zeng, Kaitlin Koo, Edward Chow, Fiona Lochray,
Laura Masucci, Renee Korol, Arjun Sahgal
University of Toronto, Toronto, ON
58
IMPROVING ACCESS TO SPECIALIZED TECHNIQUES IN CANCER
TREATMENT – AN EXAMPLE OF STEREOTACTIC RADIOSURGERY
FOR BRAIN METASTASES
1
2
1
1
2
Fred Hsu , Alan Nichol , Richard Lee , Roy Ma , Arthur Cheung ,
1
Michael McKenzie
1
2
British Columbia Cancer Agency, Abbotsford, BC; British Columbia
Cancer Agency, Vancouver, BC
59
MONTE CARLO CALCULATION OF DOSE DISTRIBUTION IN
OLIGOMETASTATIC PATIENTS PLANNED FOR SPINE
STEREOTACTIC ABLATIVE RADIOTHERAPY
Shaun Loewen, Vitali Moiseenko, I Anthony Popescu, Rose Vellani, Ming
Fong, Mitchell Liu
British Columbia Cancer Agency, Vancouver, BC
60
INTEGRATION OF DIFFUSION TENSOR TRACTOGRAPHY IN
PATIENTS WITH ARTERIOVENOUS MALFORMATION TREATED
WITH STEREOTACTIC RADIOSURGERY
1
1
1
1
Shaun Loewen , Michael McKenzie , Ermias Gete , Bradford Gill ,
1
1
1
1
Richard Lee , Kurt Luchka , Vitali Mioseenko , Chris Herbert , Brian
2
2
2
3
1
Toyota , Gary Redekop , Charles Haw , Andy Lee , Monty Martin ,
1
Yervant Arzoumanian
1
British Columbia Cancer Agency, Vancouver Cancer Centre,
2
Vancouver, BC; Vancouver General Hospital, Vancouver, BC; 3Royal
Columbian Hospital, New Westminster, BC
61
DEVELOPING THE NCIC-CTG SC 24 RANDOMIZED PHASE II SPINE
SBRT (STEREOTACTIC BODY RADIATION THERAPY) STUDY FOR
COMPLEX SPINAL METASTASES: WHAT SHOULD THE CONTROL
GROUP BE?
1
2
3
Giuseppina Laura Masucci , Rebecca Wong , Michael Brundage ,
3
3
3
2
Heather Stanton , Carolyn Wilson , Ralph Meyer , Arjun Sahgal
1
2
Université de Montréal, Montréal, QC; University of Toronto, Toronto,
3
ON; Queen's University, Kingston, ON
62
PROBABILITIES OF RADIATION MYELOPATHY SPECIFIC TO
STEREOTACTIC BODY RADIOTHERAPY TO GUIDE SAFE PRACTICE
1
2
2
3
4
Arjun Sahgal , Vivian Weinberg , Lijun Ma , Eric Chang , Sam Chao ,
5
6
7
7
Alexander Muacevic , Alessandra Gorgulho , Iris Gibbs , Scott Soltys ,
8
4
1
2
Peter Gerszten , Liliyanna Angelov , Shun Wong , David Larson
1
2
University of Toronto, Toronto, ON; University of California San
Francisco, San Francisco, CA; 3MD Anderson Cancer Center, Houston,
4
5
TX; Cleveland Clinic, Cleveland, OH; University Hospitals of Munich,
6
Munich, Germany; University of California Los Angeles, Los Angeles,
7
8
CA; Stanford, Palo Alto, CA; University of Pittsburgh, Pittsburgh, PA
63
SPINAL CORD MOTION CONSIDERATIONS FOR SPINE
STEREOTACTIC BODY RADIOTHERAPY (SBRT): DOES THE CORD
MOVE?
Chia-Lin Tseng, Marshall Sussman, Anna Simeonov, Daniel Letourneau,
Eugene Yu, Arjun Sahgal
University of Toronto, Toronto, ON
64
A PROVINCE-WIDE QUALITY ASSURANCE (QA) REVIEW OF
STEREOTACTIC BODY RADIOTHERAPY (SBRT) TREATMENT
PLANNING FOR LUNG CANCER
1
1
1
2
1
Andrea Lo , Mitchell Liu , Elisa Chan , Chad Lund , Shaun Loewen ,
1
2
1
3
Jeffrey Cao , Devin Schellenberg , Hannah Carolan , Tanya Berrang
1
2
University of British Columbia, Vancouver, BC; University of British
3
Columbia, Surrey, BC; University of British Columbia, Victoria, BC
65
LIFE CHALLENGES EXPERIENCED BY LONG-TERM PEDIATRIC
BRAIN TUMOUR SURVIVORS: PARENTS’ PERSPECTIVES
Karen Goddard, Robert Olson, Maureen Parkinson, Wendy Nurcombe,
Mary Anne Bobinski, Fuchsia Howard
British Columbia Cancer Agency, Vancouver, BC
66
SURVIVORSHIP CARE IN CANADIAN GENITOURINARY ONCOLOGY:
TOWARDS A MULTIDISCIPLINARY PERSPECTIVE
Nafisha Lalani, Ashraf Almatar, Suzanne Richter, Jackie Bender, David
Wiljer, Laura Legere, Christine Massey, Srikala Sridhar, Michael Jewett,
Pamela Catton
University of Toronto, Toronto, ON
67
SYSTEMATIC REVIEW OF EPIC QUALITY OF LIFE DATA AFTER
PROSTATE CANCER TREATMENT
1
2
2
Tsz Kin Lee , Rodney Henry Breau , Libni Eapen
1
2
The Ottawa Hospital Cancer Centre, Ottawa, ON; University of Ottawa,
Ottawa, ON
68
PILOT STUDY ON QUALITY OF LIFE AND SEXUAL FUNCTION IN
HOMOSEXUAL MEN TREATED FOR PROSTATE CANCER
1
2
2
Tsz Kin Lee , Rodney Henry Breau , Libni Eapen
1
2
The Ottawa Hospital Cancer Centre, Ottawa, ON; University of Ottawa,
Ottawa, ON
69
RADIOTHERAPY FOR INTUBATED PATIENTS WITH MALIGNANT
AIRWAY OBSTRUCTION: FUTILE, OR FACILITATING EXTUBATION?
1
2
1
1
Alexander Louie , Sophia Lane , David Palma , Jeffrey Cao , Andrew
1
1
Warner , George Rodrigues
1
2
London Regional Cancer Program, London, ON; University of Western
Ontario, London, ON
70
PROGNOSTIC UTILITY OF ANXIETY AND DEPRESSION LEVELS AT
TIME OF DIAGNOSIS IN STAGE III LUNG CANCER PATIENTS
1
2
2
Sarah Lucas , Wolfgang Linden , Robert Olson
1
2
British Columbia Cancer Agency, Vancouver, BC; University of British
Columbia, Vancouver, BC
71
CHANGES IN QUALITY OF LIFE, FUNCTIONAL ACTIVITIES, AND
COGNITIVE FUNCTION, FROM BASELINE TO 6 MONTHS POSTTREATMENT, FOR PATIENTS WITH HIGH GRADE GLIOMAS
1
1
2
Robert Olson , Maureen Parkinson , Rosemary Cashman , Michael
1
1
2
1
McKenzie , Jennifer Yao , Gina Mackenzie , Joanne Stephen
1
2
University of British Columbia, Vancouver, BC; British Columbia
Cancer Agency, Vancouver, BC
72
ENSURING HIGH QUALITY OF LIFE AS A COMPONENT OF
COMPREHENSIVE RADIATION ONCOLOGIC CARE – A PEI
PROVINCIAL STUDY
Larry Pan, Gwen MacDonald, Judy Hale, Liz Dobbin, Ethan Laukkanen
PEI Cancer Treatment Centre, Charlottetown, PE
73
OPERATING CHARACTERISTICS RELATED TO BRAIN
METASTASES PROGNOSTIC INDICES
1
1
1
1
George Rodrigues , Glenn Bauman , David Palma , Alexander Louie ,
1
2
2
Joseph Mocanu , Suresh Senan , Frank Lagerwaard
1
2
University of Western Ontario, London, ON; VU Amsterdam,
Amsterdam, Netherlands
74
CONCERNS AND PERCEPTIONS REGARDING QUALITY AND
SAFETY IN RADIATION THERAPY AMONGST CANCER PATIENTS
1
2
3
1
Caitlin Gillan , Kaleigh Briggs , Teresa Cheng , Nicole Harnett , David
1
Wiljer
1
2
University of Toronto, Toronto, ON; Princess Margaret Hospital,
3
Toronto, ON; The Michener Institute for Applied Health Sciences,
Toronto, ON
3:30-3:40
Stretch your legs and get ready for Round 2!
3:40-4:40
Poster Preview 2 - Abstract # 75-124
Moderator: Christina Parsons, Tara Roswell
75
TMPRSS2:ERG STATUS AND BIOCHEMICAL RECURRENCE
FOLLOWING RADIOTHERAPY FOR INTERMEDIATE-RISK
PROSTATE CANCER
1
1
1
1
Alan Dal Pra , Fiona Warde , Adrian Ishkanian , Alice Meng , Chad
2
2
1
1
3
Maloff , Wan Lam , Jenna Sykes , Melania Pintile , Jeremy Squire ,
1
4
1
Anthony Joshua , Gyorgy Petrovics , Theo van der Kwast , Tarek
5
1
1
1
Bismar , Andrew Evans , Michael Milosevic , Robert Bristow
1
2
University of Toronto, Toronto, ON; British Columbia Cancer Research
3
4
Centre, Vancouver, BC; Queen's University, Kingston, ON; Uniformed
5
Services University of the Health Sciences, Rockville, MD; University of
Calgary, Calgary, AB
76
GENE PROFILE ANALYSIS UNCOVERS MOLECULAR SUBTYPES OF
CERVICAL CANCER
1
1
1
1
Corinne Doll , Peter Craighead , Prafull Ghatage , Susan Lees-Miller ,
2
Anthony Magliocco
1
2
University of Calgary, Calgary, AB; Moffitt Cancer Center, Tampa, FL
77
MICRORNA-193B ENHANCES TUMOUR PROGRESSION VIA DOWN
REGULATION OF NEUROFIBROMIN 1
1
2
3
2
Michelle Lenarduzzi , Angela Hui , Nehad Alajez , Wei Shi , Justin
2
2
2
Williams , Shijun Yue , Fei Fei Liu
1
2
University of Toronto, Toronto, ON; Princess Margaret Hospital,
3
Toronto, ON; King Saud University, Riyadh, Saudi Arabia
78
HUMAN PAPILLOMA VIRUS INFECTION AND ERYTHROPOIETIN
RECEPTOR EXPRESSION AS PROGNOSTIC INDICATORS IN
OROPHARYNGEAL CANCER
1
2
2
2
Lily Shakibnia , Hani Marzouki , Eduardo Franco , Peter Chauvin ,
2
2
2
1
James Hanley , François Coutlée , Karen Kost , George Shenouda
1
2
McGill University Health Centre, Montreal, QC; McGill University,
Montreal, QC
79
COMBINING GEROSUPPRESSANTS WITH RADIOTHERAPY IN
PROSTATE AND LUNG CANCER MODELS
Thomas Corbett Tsakiridis
Juravinski Cancer Centre, Hamilton, ON
80
A POTENTIAL PROGNOSTIC MICRO-RNA SIGNATURE FOR
DISTANT METASTASIS IN SOFT-TISSUE SARCOMAS
Philip Wong, Angela Hui, Jie Su, Wei Xu, Christine How, Jeff Bruce,
Charles Catton, Jay Wunder, Irene Andrulis, Brendan Dickson, Brian
O'Sullivan, Robert Bell, Fei-Fei Liu
University of Toronto, Toronto, ON
81
DETERMINING THE USE OF IGRT FOR PRE-OPERATIVE
RADIOTHERAPY OF RETROPERITONEAL SARCOMAS
Philip Wong, Colleen Dickie, David Lee, Peter Chung, Brian O'Sullivan,
Carol Swallow, Rebecca Gladdy, Charles Catton
University of Toronto, Toronto, ON
82
COST MINIMIZATION ANALYSIS: SHOULD PARTIAL BREAST
IRRADIATION BE UTILIZED OVER WHOLE BREAST IRRADIATION?
1
1
1
1
Martin Leung , Michael Lock , Alexander Louie , George Rodrigues ,
1
2
1
David D'Souza , Robert Dinniwell , Rob Barnett
1
2
University of Western Ontario, London, ON; University of Toronto,
Toronto, ON
83
SHOULD WOMEN YOUNGER THAN 40 YEARS OF AGE WITH
INVASIVE BREAST CANCER HAVE A MASTECTOMY? 15-YEAR
OUTCOMES OF A POPULATION-BASED COHORT
Jeffrey Cao, Ivo Olivotto, Pauline Truong, Robert Olson, Mira Keyes,
Lorna Weir, Karen Gelmon, Vanessa Bernstein, Ryan Woods, Caroline
Speers, Scott Tyldesley
University of British Columbia, Vancouver, BC
84
LONG TERM MORTALITY FROM CARDIAC CAUSES AFTER
ACCELERATED HYPOFRACTIONATED VERSUS CONVENTIONAL
WHOLE BREAST RADIOTHERAPY FOR LOCALIZED LEFT-SIDED
BREAST CANCER
Elisa K. Chan, Ryan Woods, Sean Virani, Caroline Speers, Elaine Wai,
Alan Nichol, Mary L. McBride, Scott Tyldesley
University of British Columbia, Vancouver, BC
85
THE EFFECT OF A BOOST ON PATIENT REPORTED LONG-TERM
COSMETIC OUTCOME AFTER ACCELERATED
HYPOFRACTIONATED WHOLE BREAST RADIOTHERAPY FOR
LOCALIZED BREAST CANCER
Elisa K. Chan, Nazlee Tabarsi, Scott Tyldesley, Mohamed Khan, Ryan
Woods, Caroline Speers, Lorna Weir
University of British Columbia, Vancouver, BC
86
IDENTIFYING RISK FACTORS FOR LOCOREGIONAL RECURRENCE
FOLLOWING POSTMASTECTOMY RADIOTHERAPY IN BREAST
CANCER PATIENTS
1
2
2
2
3
Lynn Chang , Tim Whelan , Chu-Shu Gu , Jim Julian , Claire McMillan ,
3
2
Sue Schiff , Do-Hoon Kim
2
1
Juravinski Cancer Centre, Hamilton, ON; McMaster University,
3
Hamilton, ON; Hamilton Health Sciences, Hamilton, ON
87
MULTICENTER OUTCOMES IN WOMEN WITH BREAST DUCTAL
CARCINOMA IN SITU USING HYPOFRACTIONATED
RADIOTHERAPY
1
2
2
3
3
Lara Hathout , Tarek Hijal , Horia Vulpe , Houda Bahig , Bernard Fortin ,
3
Michael Yassa
1
2
Université de Montréal, Montreal, QC; MUHC Montreal General
3
Hospital, Montreal, QC; Hôpital Maisonneuve-Rosemont, Montreal, QC
88
TREATMENT PATTERNS AND LOCOREGIONAL RECURRENCE
OUTCOMES IN PATIENTS WITH PN0 (I+) BREAST CANCER
1
2
3
3
Irene Karam , Maria F Lesperance , Scott Tyldesley , Caroline Speers ,
2
4
Mary L. Lesperance , Pauline T Truong
1
British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC;
2
3
University of Victoria, Victoria, BC; University of British Columbia,
4
Vancouver, BC; British Columbia Cancer Agency, Vancouver Island
Centre, Victoria, BC
89
ARE THERE PATIENT SUBSETS WITH NODE-NEGATIVE BREAST
CANCER THAT MAY BENEFIT FROM REGIONAL NODAL RT? A
POPULATION-BASED ANALYSIS OF WOMEN WITH MA20-DEFINED
“HIGH-RISK, NODE-NEGATIVE” BREAST CANCER
1
2
3
Pauline Truong , Scott Tyldesley , Cheryl Alexander , Joycelin
1
2
3
Canavan , Caroline Speers , Ivo Olivotto
1
British Columbia Cancer Agency, Vancouver Island, Victoria, BC;
3
University of British Columbia, Vancouver, BC; British Columbia
Cancer Agency, Victoria, BC
2
90
PROSPECTIVE EVALUATION OF RADIATION PNEUMONITIS IN
NEOADJUVANT CONCURRENT DOCETAXEL AND RADIATION
THERAPY FOR LOCALLY ADVANCED BREAST CANCER
Alexander Louie, George Rodrigues, Abhinay Sathya, Francisco Perera,
Michael Ong, David D'Souza, Ann Chambers, Muriel Brackstone
London Regional Cancer Program, London, ON
91
TISSUE EXPANDER/IMPLANT BREAST RECONSTRUCTION WITH
AND WITHOUT POSTMASTECTOMY RADIATION: PREDICTIVE
FACTORS FOR COMPLICATIONS
1
1
2
3
Sonia Kim Anh Nguyen , Paul Oxley , Rashin Rastagar , Michel Joffres ,
4
Winkle Kwan
1
British Columbia Cancer Agency, Fraser Valley Centre, Surrey, BC;
2
3
University of British Columbia, Surrey, BC; University of British
4
Columbia, Vancouver, BC; Simon Fraser University, Surrey, BC;
92
INCIDENCE AND OUTCOME OF SYMPTOMATIC VENOUS
THROMBOEMBOLISM IN PATIENTS WITH GLIOBLASTOMA
MULTIFORME IN SOUTHERN ALBERTA
1
1
2
Clement Ho , Jacob Easaw , Gerald Lim ,
1
2
University of Calgary, Calgary, AB; Tom Baker Cancer Centre, Calgary,
AB
93
FACTORS INFLUENCING OVERALL SURVIVAL SPECIFIC TO ADULT
LOW-GRADE ASTROCYTOMA: A POPULATION-BASED STUDY
Sarah Ironside, James Perry, May Tsao, Todd Mainprize, Julia Keith,
Normand Laperriere, Lawrence Paszat, Arjun Sahgal
University of Toronto, Toronto, ON
94
MRI AND US IN THE FOLLOW-UP OF CHOROIDAL MELANOMA: DO
THEY CORRELATE?
Rolina Al-Wassia, Fabricio Gonclaves, Crystal Holly, Jeffry Chankowsky,
George Shenouda
McGill University Health Centre, Montreal, QC
95
TREATMENT AND OUTCOMES OF PATIENTS WITH LIMITED STAGE
PRIMARY CUTANEOUS B-CELL LYMPHOMA
1
2
1
2
Sarah Hamilton , Elaine Wai , King Tan , Cheryl Alexander , Randy
1
1
Gascoyne , Joseph Connors
1
2
British Columbia Cancer Agency, Vancouver, BC; British Columbia
Cancer Agency, Victoria, BC
96
NATURAL KILLER/T CELL LYMPHOMA: A CANADIAN SINGLE
INSTITUTION EXPERIENCE
1
2
2
Jim Rose , Kerry Savage , Christina Aquino-Parsons
1
2
Cancer Centre of Southeastern Ontario, Kingston, ON; British
Columbia Cancer Agency, Vancouver, BC
97
PILOT STUDY INVESTIGATING THE EFFECTS OF PROPHYLACTIC
CRANIAL IRRADIATION ON NEUROCOGNITIVE FUNCTION IN
PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER
1
2
1
Daniel Bernad , Alexandra Fiocca , George Shenouda , Valerie Panet1
1
1
1
Raymond , Paul Giacomini , Raquel del Carpio , Luis Souhami
1
2
McGill University, Montreal, QC; Ryerson University, Toronto, ON
98
ROLE OF DOSE ESCALATION IN THORACIC RADIOTHERAPY FOR
LIMITED-STAGE SMALL CELL LUNG CANCER: ANALYSIS OF THE 15
YEAR EXPERIENCE FROM A RETROSPECTIVE COHORT OF 296
PATIENTS AT THE OTTAWA HOSPITAL CANCER CENTRE (TOHCC)
Vimoj Janardanan Nair, Abby Sirisegaram, Garth Nicholas, Ranjeeta
Mallick, Scott Laurie, Robert MacRae
University of Ottawa, Ottawa, ON
99
CHEMORADIATION WITH ACCELERATED BOOST FOR STAGE III
NONSMALL CELL LING CANCER
1
1
1
2
Ethan Laukkanen , Larry Pan , Philip Champion , Faraz Khan , D.
1
1
Dryer , Christina Schipper ,
1
2
Queen Elizabeth Hospital PEI, Charlottetown, PE; Dubai, United Arab
Emirates
100
PILOT DOSIMETRIC STUDIES OF INTENSITY MODULATED VERSUS
3D-CONFORMAL RADIOTHERAPY FOR LOCALLY ADVANCED NONSMALL CELL LUNG CANCER (LA-NSCLC)
Lindsay Mathew, Jack Skozny, Joe Szabo, Orest Ostapiak, James
Wright, Gordon Okawara, Ranjan Sur, Anand Swaminath, Thomas
Corbett Tsakiridis, Theodoros Tsakiridis
Juravinski Cancer Centre, Hamilton, ON
101
PREDICTING SYMPTOMATIC RADIATION PNEUMONITIS AFTER
CONCURRENT CHEMORADIOTHERAPY FOR NON-SMALL CELL
LUNG CANCER: RESULTS OF AN INTERNATIONAL INDIVIDUAL
PATIENT DATA META-ANALYSIS
1
2
3
4
David Palma , Suresh Senan , Kayoko Tsujino , Robert Barriger ,
5
6
7
8
Ramesh Rengan , Marta Moreno , Jeffrey Bradley , Tae Hyun Kim ,
9
10
11
1
Sara Ramella , Lawrence Marks , Luigi De Petris , Larry Stitt , George
1
Rodrigues
1
2
London Regional Cancer Program, London, ON; VU University Medical
3
Center, Amsterdam, Netherlands; Hyogo Cancer Center, Hyogo,
4
Japan; Indiana University School of Medicine, Indianapolis, IN;
5
6
University of Pennsylvania, Philadelphia, PA; Clínica Universidad de
7
Navarra, Pamplona, Spain; Washington University School of Medicine,
8
9
St. Louis, MO; National Cancer Center, Goyang, Korea; Campus Bio10
Medico University, Rome, Italy; University of North Carolina, Chapel
11
Hill, NC; Karolinska University Hospital Solna, Stockholm, Sweden
102
DELINEATION VARIABILITY ON PLANNING CT AND CONE-BEAM CT
WHEN CONTOURING THE BLADDER AS AN ORGAN-AT-RISK
1
2
1
1
Tara Rosewall , Jason Xie , Andrew Bayley , Peter Chung , Geoffrey
3
3
1
Currie , Janelle Wheat , Michael Milosevic
1
2
University of Toronto, Toronto, ON; Princess Margaret Hospital,
3
Toronto, ON; Charles Sturt University, Wagga Wagga, New South
Wales, Australia
103
DOSIMETRIC COMPARISONS BETWEEN THREE-DIMENSIONAL
CONFORMAL RADIOTHERAPY (3D-CRT) AND INTENSITY
MODULATED RADIATION THERAPY USING HELICAL
TOMOTHERAPY (HT) IN PATIENTS WITH HEAD AND NECK
SQUAMOUS CELL CARCINOMA (HNSCC)
Joel Broomfield, Hussain AlHussain, Alain Haddad, Saif Al-Thaqfi, Samy
El-Sayed, Robert Zohr, Yves Deshaies, Kathy Carty, Jason Belec, Ionut
Busca
University of Ottawa, Ottawa, ON
104
IS PERCENTAGE OF WEIGHT LOSS PREDICTIVE OF THE NEED
FOR RE-PLANNING OF PATIENTS WITH HEAD AND NECK
SQUAMOUS CELL CARINOMA (HNSCC) TREATED WITH INTENSITYMODULATED RADIOTHERAPY (IMRT)? RESULTS OF A
PROSPECTIVE STUDY
Joel Broomfield, Samy El-Sayed, Hussain AlHussain, Ionut Busca, Stacy
Yemchuk, University Jamie Bahn
University of Ottawa, Ottawa, ON
105
THE INCIDENCE OF TREATMENT MODIFICATION BASED ON DAILY
CONE BEAM CT ASSESSMENT FOR HEAD AND NECK CANCER
PATIENTS
Carla Cerase, James Loudon, Brian O'Sullivan, John Kim, John Waldron,
Laura Dawson, Stephen Breen
Princess Margaret Hospital, Toronto, ON
106
THE CHARACTERISTICS OF CERVICAL LYMPH NODE RESOLUTION
FOLLOWING PRIMARY RADIOTHERAPY +/- CHEMOTHERAPY FOR
N2-N3 HEAD AND NECK CANCER
1
1
1
1
Sophie Huang , Brian O'Sullivan , Wei Xu , Helen Zhao , Duo-Duo
2
1
1
1
1
Chen , Kelvin Chan , Andrew Hope , John Kim , Jolie Ringash , Laura A.
1
1
1
1
Dawson , Andrew Bayley , B.C. John Cho , David Goldstein , Ralph
1
1
Gilbert , John N. Waldron
1
2
University of Toronto, Toronto, ON; Princess Margaret Hospital,
Toronto, ON
107
CAN RADIOLOGICAL CHANGES DURING TREATMENT PREDICT
SUCCESS OF RADIATION THERAPY IN PATIENTS WITH LOCALLY
ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
(HNSCC)?
Sanju Mishra, Alexander Hammond, Nancy Read, Varagur Venkatesan,
Eric Winquist, Anthony Nichols, David Palma
University of Western Ontario, London, ON
108
25 YEAR SURVIVAL OUTCOMES FOR SQUAMOUS CELL
CARCINOMAS OF THE HEAD AND NECK: POPULATION BASED
OUTCOMES FROM A CANADIAN PROVINCE
1
2
1
1
Robert Olson , Frances Wong , Jonn Wu , John Hay
1
2
University of British Columbia, Vancouver, BC; British Columbia Cancer
Agency, Fraser Valley Centre, Surrey, BC
109
QUALITY OF LIFE OUTCOMES WITH COMBINED SPARING OF
PAROTID AND SUBMANDIBULAR GLANDS IN HEAD AND NECK
IMRT
1
2
2
2
Rufus Scrimger , Hadi Seikaly , Matthew Parliament , Lisa Capelle ,
2
2
2
Jeffrey Harris , David Williams , Naresh Jha
1
2
Cross Cancer Institute, Edmonton, AB; University of Alberta,
Edmonton, AB
110
EVALUATION OF SKIN DOSE DISTRIBUTION IN HEAD AND NECK
CANCER PATIENTS REQUIRING RADIATION THERAPY WITH
COVERAGE OF THE TRACHEOSTOMY SITE
Julia Skliarenko, Ananth Ravi, Justin Lee
University of Toronto, Toronto, ON
111
MCGILL EXPERIENCE WITH HEAD AND NECK RE-IRRADIATION
1
1
2
1
Siavosh Vakilian , Rolina Al-Wassia , Crystal Holly , Khalil Sultanem ,
2
George Shenouda
1
2
McGill University, Montreal, QC; McGill University Health Centre,
Montreal, QC
112
CORRELATION OF NECK NODAL LEVELS WITH THE RISK OF
DISTANT METASTASIS IN PATIENTS WITH HEAD AND NECK
SQUAMOUS CELL CARCINOMA
Hussain Al Hussain, Ionut Busca, Samy El-Sayed, Libni Eapen
University of Ottawa, Ottawa, ON
113
TUMOUR CONTROL AND COSMETIC OUTCOMES OF
ORTHOVOLTAGE RADIOTHERAPY FOR MEDIAL CANTHAL BASAL
CELL CARCINOMAS
Evelyn Herrmann, H Krema, David Payne, Rand Simpson, Normand
Laperriere, Caroline Chung
Princess Margaret Hospital, Toronto, ON
114
PREDICTORS OF RADIOTHERAPY FAILURE IN NON MELANOMA
SKIN CANCER
Luluel Khan, Dale Breen, Lying Zhang, Judith Balogh, Greg Czarnota,
Justin Lee, May Tsao, Elizabeth Barnes
University of Toronto, Toronto, ON
115
ELECTRON THERAPY FOR NON-MELANOMA SKIN CANCERS:
COMPUTER SIMULATED BOLUS VERSUS ACTUAL PHYSICAL
BOLUS FOR TREATMENT PLANNING
Darwin Yip, Greg Salomons, Gary Bracken, Michael Brundage
Queen's University, Kingston, ON
116
ARE WEB-BASED RESOURCES THE BREAST? : AN EVALUATION
OF THE QUALITY OF ONLINE RESOURCES FOR BREAST CANCER
PATIENTS
1
2
2
2
Paris-Ann Ingledew , Baljeet Brar , Julia Lin , Glenn Regehr , Sonia Kim
1
Anh Nguyen
1
2
University of British Columbia, Surrey, BC; University of British
Columbia, Vancouver, BC
117
CONTINUITY CLINICS IN ONCOLOGY TRAINING PROGRAMS IN
CANADA
1
2
2
3
Jennifer Croke , Michael Vickers , Daniel Heng , Martin Reaume , Xinni
3
3
3
3
3
Song , Joanne Meng , Tim Asmis , Catherine Lochrin , Choan E
1
2
University of Ottawa, Ottawa, ON; Tom Baker Cancer Centre, Calgary,
3
AB; The Ottawa Hospital, Ottawa, ON
118
REDUCING PATIENT WAIT TIMES FOR RADIATION THERAPY AND
IMPROVING RADIATION TREATMENT PLANNING EFFICIENCY WITH
THE AID OF A DISCRETE-EVENT SIMULATION MODEL
1
1
1
1
Inge Aivas , Vusal Babashov , Mehmet Begen , Michael Lock , Jeffrey
2
1
1
1
Cao , Derrick Fournier , David D'Souza , George Rodrigues , Greg
1
Zaric
1
2
University of Western Ontario, London, ON; University of British
Columbia, Vancouver, BC
119
ONLINE OPTIMIZATION OF RADIOTHERAPY PATIENT SCHEDULING
1
2
1
Antoine Legrain , Marie-Andree Fortin , Nadia Lahrichi , Louis-Martin
1
Rousseau
1
2
Ecole Polytechnique de Montreal, Montreal, QC; Universite de
Montreal, Montreal, QC
120
OPTIMAL SCHEDULING OF RADIATION THERAPISTS BASED ON
PATIENT, STAFF AND ORGANIZATIONAL CONSIDERATIONS
John French, Vincent Chow, Pablo Santibanez, Martin Puterman, Scott
Tyldesley
University of British Columbia, Vancouver, BC
121
FROM DATA TO KNOWLEDGE – CREATING A PROVINCIAL
PERFORMANCE METRICS SYSTEM BY USING DATA CONTAINED
WITHIN THE ARIA PRODUCTION DATABASE
John French, Vincent Chow, Pablo Santibanez, Martin Puterman, Scott
Tyldesley
University of British Columbia, Vancouver, BC
122
RADIOTHERAPY RESOURCES IN AFRICA: AN IAEA UPDATE ON
THE CURRENT STATUS AND NEEDS
1
2
2
Jean-Marc Bourque , May Abdel-Wahab , Ed Rosenblatt , Debbie Van
2
2
2
2
der Merwe , Yaroslav Pynda , Joanna Izewska , Ahmed Meghzifene
1
2
London Regional Cancer Program, London, ON; International Atomic
Energy Agency, Vienna, Austria
123
GLOBAL HEALTH IN POSTGRADUATE MEDICAL EDUCATION:
RESULTS OF A NATIONAL SURVEY AND A LITERATURE REVIEW
1
2
3
Jean-Marc Bourque , Mark Masterson , Keren Mandelzweig , Gabe
1
Boldt
1
2
University of Western Ontario, London, ON; University of Bristish
3
Columbia, Vancouver, BC; University of Manitoba, Winnipeg, MB
124
A PHASE II STUDY OF AN INFORMATIONAL DVD TO ENHANCE
CLINICAL TRIAL ACCRUAL IN BREAST CANCER PATIENTS
Heidi Wong, Catherine Ennis, Alan Nichol, Lorna Weir, Scott Tyldesley,
Mira Keyes, Hannah Carolan, Christina Aquino-Parsons
University of British Columbia, Vancouver, BC
4:45-6:15
Annual General Meeting
Facilitators: Andrea Bezjak and Board of Directors
6:15-7:30
Reception – Ottawa Convention Centre
Level 2
Friday September 14, 2012
6:30-7:30
CROF Fun Run/Walk
Meet in the lobby of Hotel
7:30-8:50
Breakfast and Registration
Level 2
Meet and Greet for Award Winners and Sponsors
Room 201
8:50-9:00
Welcome and Introductions
Room 205-208
Jason Pantarotto
Mary Gospodarowicz
9:00-10:00
Gordon Richards Lecture
Next-Gen Radiation Oncology
Fei-Fei Liu
10:00-11:00
Break and Poster Viewing
Room 213-215
11:00-12:30
Canadian Brachytherapy Group
Room 205-208
Moderator: Boris Bahoric
11:00-11:50
Canadian Brachytherapy Group Keynote Address and AGM
Title
Mihai Ghilezan
11:50-12:00
125
URINARY TOXICITY DECLINE IN 2011 PROSTATE
BRACHYTHERAPY PATIENTS WITH LONG TERM FOLLOW UP; BC
PROVINCIAL PROSTATE BRACHYTHERAPY PROGRAM OUTCOMES
Elisa K. Chan, Mira Keyes, Tom Pickles Vincent Lapointe, Ingrid
Spadinger, Michael Mckenzie, W. James Morris
British Columbia Cancer Agency, Vancouver, BC
12:00-12:10
126
MRI GUIDED HIGH DOSE RATE VAGINAL INTERSTITIAL
BRACHYTHERAPY FOR LOCALLY RECURRENT VAGINAL CANCERS
Nikhilesh Patil, George Hajdok, Gail McBrayne, Kathleen Surry, Akira
Sugimoto, Michel Prefontaine, Leanne Derrah, Tammie Murray, Andrea
Lum, David D'Souza
University of Western Ontario, London, ON
12:10-12:20
127
OPTIMAL OUTCOME AFTER PERMANENT SEED PROSTATE
BRACHYTHERAPY: THE TRIFECTA ANALYSIS
1
2
1
Audrey Tetreault-Laflamme , Thomas Zilli , Guila Delouya , Daniel
1
Taussky
1
2
Centre Hospitalier de l'Université de Montréal, Montreal, QC ; Hôpital
Universitaire de Genève, Genève, Switzerland
12:20-12:30
128
MRI-GUIDED BRACHYTHERAPY PROCESS FOR CERVICAL
CANCER: IDENTIFY PROCEDURE TIME & OPPORTUNITIES FOR
EFFICIENCIES
1
2
2
2
Kitty Chan , Tara Rosewall , Brenda Kenefick , Mike Milosevic
1
2
Princess Margaret Hospital, Toronto, ON; University of Toronto,
Toronto, ON
12:30-1:30
Canadian Brachytherapy Group Annual General Meeting
Facilitator: Boris Bahoric
12:30-2:30
Lunch – on your own
Industry Symposium – Varian Room 209
Committee Meetings
2:30-4:00
Workshops
1
Adjuvant Therapy for Endometrial Cancer
Room 201
Facilitator: Ida Ackerman
Objectives: At the end of this session the learner will:
• appreciate the pros and cons of adjuvant radiotherapy for
endometrial cancer using cases as illustration.
• understand the controversies and potential role of adjuvant
chemotherapy for endometrial cancer.
• understand the potential advantages and disadvantages of
IMRT for adjuvant pelvic radiotherapy.
2
Quality in a Radiation Program
Room 203
Facilitator: Glenn Jones
Objectives: At the end of this session the learner will:
• have criteria to identify, map and align activities and points of
information exchange or interaction within a cancer program
across a clinical trajectory.
• rebalance Quality of Decisions Treatment and Life.
• describe infrastructures supporting and sustaining a Qualitybased clinical program.
• apply this method to one’s own loco-regional context.
3
LUNG SBRT – Beyond the Obvious
Room 204
Facilitators: Andrea Bezjak, Patrick Cheung, Rob MacRae, David
Palma, Anand Swaminath
Objectives: At the end of this session the learner will:
• become aware of different ways in which centers deal with
SBRT lung for lesions that is very close to a critical organ at
risk.
• reflect on the clinical and technical issues that may make a
patients with early stage NSCLC not a candidate for SBRT.
• have a better understanding of the issues related to
evaluation of radiological response after lung SBRT.
• consider what type of patient with oligometastatic disease
would be suitable for treatment with lung SBRT.
4
Leadership Workshop – Developing Leaders of Excellence,
Succession Planning and Mentoring the Leaders of Tomorrow
Facilitators: Chandra Martens, Peter Craighead, Michael Lock,
Ross Halperin, Padraig Warde, Woodrow Wells, Ethan Lyn,
Mary Gospodarowicz
Room 103
Objectives: At the end of this session the learner will:
• hear from current key leaders and experts who have an
understanding of, and practical tools, to mentor and to
develop both new and existing leaders in our Oncology
centres.
• enhance succession planning, leadership development, and
encourage team building and positive working relationships
between multidisciplinary teams working together.
• be given practical advice and tools from the key medical
leaders, based on experience and research in succession
planning, and have these tools available to apply in their own
centres.
5
Image-guided Brachytherapy “Beyond the Seed”
Facilitators: Juanita Crook, Gerard Morton, Jean-Philippe Pignol,
Té Vuong
Room 104
Objectives: At the end of this session the learner will:
• be aware of the use of image guidance in the delivery of
brachytherapy that expands indications into new and exciting
territory.
• be familiar with patient selection, technical aspects and
physics considerations in situations such as guided breast
seed brachytherapy, US-guided interstitial HDR gyne
brachytherapy, US planned DHR prostate brachytherapy
and ano-rectal HDR Brachytherapy.
2:30-4:00
Oral Session 1 Clinical – Breast and Head and Neck
Room 205/207
Moderator: Alia Norman
Objectives:
•
•
To review Breast Cancer recurrence risks and how to mitigate these
risks.
To review outcomes in the treatment of Head and Neck Cancers.
2:30-2:40
129
IDENTIFICATION OF PATIENTS AT VERY LOW RISK OF LOCAL
RECURRENCE AFTER BREAST CONSERVING SURGERY AND
RADIATION
Sally Smith, Pauline Truong, Mary Lesperance, Linghong Lu, Ivo Olivotto
University of British Columbia, Victoria, BC
2:40-2:50
130
RADIOTHERAPY IN THE TREATMENT OF LUMINAL A BREAST
CANCER: IMPACT ON HEALTH CARE COST IN CANADA
1
2
1
3
Mei Ling Yap , Jean Yong , Jeffrey Hoch , Eric Gutierrez , Padraig
1
1
1
Warde , Anthony Fyles , Fei-Fei Liu
1
2
University of Toronto, Toronto, ON; Canadian Centre for Applied
3
Research in Cancer Control, Toronto, ON; Cancer Care Ontario,
Toronto, ON
2:50-3:00
131
MULTIFOCAL/MULTICENTRIC BREAST CANCER IS ASSOCIATED
WITH INCREASED LOCAL RECURRENCE.
Tiffany Tam, Shelly Hayes, Tianyu Li, Lori Goldstein, Marcia Boraas,
Richard Bleicher, Elin Sigurdson, Paula Ryan, Penny Anderson
Fox Chase Cancer Center, Philadelphia, PA
3:00-3:10
132
MATURE CLINICAL RESULTS OF A PROSPECTIVE CLINICAL TRIAL
EVALUATING INTENSITY MODULATED RADIATION THERAPY BY
TOMOTHERAPY (IMRT-HT) FOR LOCO REGIONAL BREAST
RADIATION
Jean-Michel Caudrelier, Bernd Esche, Joanne Meng, Lynn Montgomery,
Liz O'Neil, Laval Grimard
Ottawa Hospital Regional Cancer Centre, Ottawa, ON
3:10-3:20
133
NODAL AID: A NOVEL DYNAMIC ANATOMIC LEARNING ATLAS FOR
IMPROVING DELINEATION IN THE RADIOTHERAPY TREATMENT
PLANNING OF ADVANCED BREAST CANCERS
1
1
2
Robert Dinniwell , Grace Lee , Michael Lock
1
2
University of Toronto, Toronto, ON; University of Western Ontario,
London, ON
3:20-3:30
134
LOCAL RECURRENCE RISK IN WOMEN WITH STAGE I BREAST
CANCER IS DECLINING OVER TIME
1
1
1
2
Joycelin Canavan , Pauline Truong , Sally Smith , Linghong Lu , Mary
2
2
Lesperance , Ivo Olivotto
1
British Columbia Cancer Agency, Vancouver Island, Victoria, BC;
2
University of Victoria, Victoria, BC
3:30-3:40
135
OUTCOME OF INTENSITY-MODULATED RADIATION THERAPY FOR
HYPOPHARYNGEAL CANCER COMPARED TO CONVENTIONAL
RADIOTHERAPY
Isabelle Gauthier, Gary Mok, Haiyan Jiang, Shao Hui Huang, Kelvin
Chan, Ian J. Witterick, Brian O'Sullivan, John N. Waldron, Andrew J.
Bayley, John B. Cho, Bernard J. Cummings, Laura A. Dawson, Andrew
J. Hope, John J. Kim, Jolie Ringash
Princess Margaret Hospital, Toronto, ON
3:40-3:50
136
PATTERNS OF FAILURE IN PATIENTS TREATED WITH INTENSITY
MODULATED RADIATION THERAPY (IMRT) USING HELICAL
TOMOTHERAPY (HT) FOR HEAD AND NECK SQUAMOUS CELL
CARCINOMA (HNSCC), RESULTS OF A PROSPECTIVE TRIAL
Hussain Al Hussain, Ionut Busca, Kathy Carty, Joel Broomfield, Samy ElSayed, Libni Eapen, Bernd Esche, Laval Grimard
University of Ottawa, Ottawa, ON
3:50-4:00
137
DOES THE TIMING OF POST-RT PET-CT AFFECT ITS RELIABILITY
IN PREDICTING TREATMENT OUTCOMES OF HEAD AND NECK
SQUAMOUS CELL CARCINOMA: A RETROSPECTIVE ANALYSIS OF
THE BRITISH COLUMBIA CANCER AGENCY EXPERIENCE, 20052010
1
1
2
2
Hosam Kader , Leanne Dickau , Tarnjit Parhar , Pete Tonseth , Francois
2
1
1
2
2
Benard , Sally Smith , Cheryl Alexander , John Hay , Don Wilson
1
2
British Columbia Cancer Agency, Victoria, BC; British Columbia Cancer
Agency, Vancouver, BC
4:00-4:30
Break
4:30-6:00
Oral Session 2 Clinical - Prostate
Room 206/208
Moderator: William Foster
Objectives:
• To Review prostate cancer treatment outcomes.
4:30-4:40
138
PATIENT DECISION AIDS HELP EARLY-STAGE PROSTATE CANCER
PATIENTS
1
1
1
Deb Feldman-Stewart , Michael Brundage , Christine Tong , Rob
1
2
3
4
Siemens , Shabbir Alibhai , Tom Pickles , John Robinson
1
2
Queen's University, Kingston, ON; University Health Network, Toronto,
3
4
ON; British Columbia Cancer Agency, Vancouver, BC; University of
Calgary, Calgary, AB
4:40-4:50
139
WHO DIES FROM PROSTATE CANCER? AN ANALYSIS OF THE
SEER DATABASE
Scott Morgan, Rodney Breau, Wayne Kendal
University of Ottawa, Ottawa, ON
4:50-5:00
140
PROGNOSTIC VALUE OF CIRCULATING TUMOUR CELLS IN
PROSTATE CANCER PATIENTS UNDERGOING ADJUVANT OR
SALVAGE RADIATION THERAPY
1
2
2
Tracy Sexton , Lori Lowes , Alison Allan
1
2
London Regional Cancer Program, London, ON; University of Western
Ontario, London, ON
5:00-5:10
141
A RANDOMIZED PHASE III STUDY OF SHORT TERM HORMONAL
THERAPY AND DOSE ESCALATED RADIATION THERAPY FOR
LOCALIZED PROSTATE CANCER
1
2
1
1
Rachel Glicksman , Gary Mok , Jenna Sykes , Andrew Bayley , Peter
1
1
1
1
Chung , Robert Bristow , Mary Gospodarowicz , Charles Catton ,
1
1
Michael Milosevic , Padraig Warde
1
2
Queen's University, Kingston, ON; University of Toronto, Toronto, ON
5:10-5:20
142
IMPACT OF NEOADJUVANT ANDROGEN DEPRIVATION ON
FIDUCIAL MARKER MIGRATION IN EXTERNAL BEAM
RADIOTHERAPY FOR PROSTATE CANCER
Daniel Taussky, Jean-François Carrier, Marie-Claude Beauchemin, Thu
Van Nguyen, Dominic Béliveau-Nadeau, David A. Tiberi
Université de Montréal, Montreal, QC
5:20-5:30
143
THE PROSTATE CANCER RISK STRATIFICATION (PROCARS)
PROJECT: DATABASE CONSTRUCTION AND OUTCOME ANALYSIS
1
2
3
George Rodrigues , Sandra Gonzalez-Maldonado , Himu Lukka ,
4
5
6
7
Padraig Warde , Michael Brundage , Luis Souhami , Juanita Crook ,
8
4
4
9
Fabio Cury , Charles Catton , Gary Mok , Andre-Guy Martin , Eric
10
11
11
Vigneault , Jim Morris , Tom Pickles
1
2
University of Western Ontario, London, ON; University of Waterloo,
3
4
Waterloo, ON; McMaster University, Hamilton, ON; University of
5
6
Toronto, Toronto, ON; Queen's University, Kingston, ON; McGill
7
University, Montreal, QC; British Columbia Cancer Agency, Kelowna,
8
9
BC; McGill University, Montreal, QC; Universite Laval, Laval, QC;
10
11
Universite Laval, Laval, QC, University of British Columbia,
Vancouver, BC
5:30-5:40
144
THE PROSTATE CANCER RISK STRATIFICATION (PROCARS)
PROJECT: RECURSIVE PARTITIONING RISK STRATIFICATION
ANALYSIS
1
2
3
George Rodrigues , Sandra Gonzalez-Maldonado , Himu Lukka ,
4
5
6
7
Padraig Warde , Michael Brundage , Luis Souhami , Juanita Crook ,
8
4
4
9
Fabio Cury , Charles Catton , Gary Mok , Andre-Guy Martin , Eric
10
11
11
Vigneault , Jim Morris , Tom Pickles
1
2
University of Western Ontario, London, ON; University of Waterloo,
3
4
Waterloo, ON; McMaster University, Hamilton, ON; University of
5
6
Toronto, Toronto, ON; Queen's University, Kingston, ON; McGill
7
University, Montreal, QC; British Columbia Cancer Agency, Kelowna,
8
9
BC; McGill University, Montreal, QC; Universite Laval, Laval, QC;
10
11
Universite Laval, Laval, QC, University of British Columbia,
Vancouver, BC
5:40-5:50
145
POPULATION-BASED 10 YEAR EVENT-FREE SURVIVAL AFTER
RADICAL PROSTATECTOMY FOR PATIENTS WITH PROSTATE
CANCER IN BRITISH COLUMBIA
Scott Tyldesley, Jill Quirt, William Morris, Micheal Peacock, Alan So,
Charmaine Kim-Sing, Tom Pickles
University of British Columbia, Vancouver, BC
5:50-6:00
146
DOES PHOENIX FAILURE DEFINITION APPLY TO EBRT + HDR
BRACHYTHERAPY BOOST IN PROSTATE CANCER?
André-Guy Martin, Eric Vigneault, Sylviane Aubin, Nicolas Varfalvy, Luc
Beaulieu, Philippe Despré
L'Hôtel-Dieu de Québec, Quebec, QC
4:30-6:00
Oral Session 3 – Technology
Room 205/207
Moderator: Cynthia Araujo, David Bowes
Objectives:
• To review Quality Assurance issues in Radiation Oncology.
• To review Stereotactic Radiotherapy in Canada: past outcomes,
present scope of practice and future planning issues.
4:30-4:40
147
PEER-REVIEW OF RADIATION TREATMENT PLANNING ACTIVITIES
IN A PROVINCIAL RADIATION ONCOLOGY PROGRAMME: A
SURVEY OF CURRENT PRACTICE
1
2
3
4
Michael Brundage , Sophie Foxcroft , Tom McGowan , Michael Sharpe ,
5
4
Eric Gutierrez , Padraig Warde
1
2
Cancer Centre of Southern Ontario, Kingston, ON; Princess Margaret
3
Hospital, Toronto, ON; Credit Valley Hospital, Mississauga, ON;
4
5
University of Toronto, Toronto, ON; Cancer Care Ontario, Toronto, ON
4:40-4:50
148
PHYSICIAN REVIEW AND QA OF CONTOURS DRAWN FOR
RADICAL RADIOTHERAPY
Marco Carlone, Glenn Jones, Gaylene Medlam, Tom McGowan
Credit Valley Hospital, Mississauga, ON
4:50-5:00
149
A PROSPECTIVE STUDY TO DETERMINE INTEROBSERVER
VARIABILITY OF GTV WITH FDG-PET-CT COMPARED TO CT ALONE
IN STAGE III NON-SMALL CELL LUNG CANCER USING 3D ANALYSIS
1
2
2
2
David Peterson , Bashir Bashir , Shahida Ahmed , Sandor Demeter ,
2
2
2
2
Amit Chowdhury , Boyd McCurdy , Ryan Rivest , Zoann Nugent , Pam
2
Brechin
1
2
Cancer Care Manitoba, Winnipeg, MB; University of Manitoba,
Winnipeg, MB
5:00-5:10
150
IDENTIFYING AND MITIGATING RISK IN AFTER HOURS RADIATION
TREATMENT DELIVERY
Crystal Angers, Julie Renaud, Brenda Clark
Ottawa Hospital Cancer Centre, Ottawa, ON
5:10-5:20
151
DOES THE APPLICATION OF FAILURE MODE AND EFFECTS
ANALYSIS IDENTIFY AND REDUCE RISK FOR A TOMOTHERAPY
TREATMENT PROCESS?
Jamie Bahm, Ryan Studinski, Daniel La Russa, Kathy Carty, Danielle
Fraser, Lesley Buckley, Crystal Angers, Brenda Clark
University of Ottawa, Ottawa, ON
5:20-5:30
152
LUNG, LIVER, AND SPINE STEREOTACTIC BODY RADIOTHERAPY
(SBRT): CANADIAN ASSOCIATION OF RADIATION ONCOLOGY
(CARO) SCOPE OF PRACTICE GUIDELINES
1
2
3
1
Arjun Sahgal , David Roberge , Devin Schellenberg Tom Purdie ,
4
5
2
6
Anand Swaminanth , Jason Pantarotto , Edith Filion , Zolt Gabos , Jim
7
1
2
8
Butler , Daniel Letourneau , Giuseppina Masucci , Liam Mulroy , Andrea
1
1
6
Bezjak , Laura Dawson , Matthew Parliament
1
2
University of Toronto, Toronto, ON; University of Montreal, Montreal,
3
4
QC; University of British Columbia, Vancouver, BC; McMaster
5
6
University, Hamilton, ON; University of Ottawa, Ottawa, ON; University
7
of Alberta, Edmonton, AB; University of Manitoba, Winnipeg, MB;
8
Dalhousie University, Halifax, NS
5:30-5:40
153
TECHNOLOGY RESOURCE PLANNING IN RADIATION ONCOLOGY:
AN APPLICATION OF A NEEDS BASED ANALYTICAL FRAMEWORK
TO RADIOSURGERY PLANNING IN ONTARIO
Jeffrey Greenspoon, Daria O'Reilly, Anthony Whitton, James Wright,
Jonathan Sussman, Stephen Birch
McMaster University, Hamilton, ON
5:40-5:50
154
ESTIMATING THE NEED FOR STEREOTACTIC ABLATIVE
RADIOTHERAPY (SABR) FOR LUNG CANCER: AN EVIDENCEBASED EPIDEMIOLOGIC APPROACH
1
2
3
2
Jeffrey Cao , Devin Schellenberg , Islam Mohamed , Chad Lund ,
4
4
4
1
Alexander Louie , David Palma , George Rodrigues , Robert Olson ,
1
Scott Tyldesley
1
2
University of British Columbia, Vancouver, BC; University of British
3
Columbia, Surrey, BC; University of British Columbia, Kelowna, BC;
4
University of Western Ontario, London, ON
5:50-6:00
155
PITUITARY ADENOMAS TREATED WITH FRACTIONATED
STEREOTACTIC RADIOTHERAPY: CLINICAL OUTCOME AND
TOXICITY
1
1
1
2
Richard Tsang , Houman Pebdani , Nikhilesh Patil , Idara Edem , Alisha
1
1
1
Albert-Green , Monique van Prooijen , Mostafa Heydarian , Shenaz
1
1
1
Ladak , Gelareh Zadeh , James Brierley
1
2
University of Toronto, Toronto, ON; Queen's University, Toronto, ON
6:45
Dinner and Awards Ceremony
Museum of Civilization – Canada Hall
100, rue Laurier Street, Gatineau
Saturday September 15, 2012
7:15-8:00
Breakfast and Registration
7:30-9:00
Workshops
1
Adjuvant Therapy for Endometrial Cancer
Room 201
Facilitator: Ida Ackerman
Objectives: At the end of this session the learner will:
• appreciate the pros and cons of adjuvant radiotherapy for
endometrial cancer using cases as illustration.
• understand the controversies and potential role of adjuvant
chemotherapy for endometrial cancer.
•
2
understand the potential advantages and disadvantages of
IMRT for adjuvant pelvic radiotherapy.
Quality in a Radiation Program
Room 203
Facilitator: Glenn Jones
Objectives: At the end of this session the learner will:
• have criteria to identify, map and align activities and points of
information exchange or interaction within a cancer program
across a clinical trajectory.
• rebalance Quality of Decisions Treatment and Life.
• describe infrastructures supporting and sustaining a Qualitybased clinical program.
• apply this method to one’s own loco-regional context.
3
LUNG SBRT – Beyond the Obvious
Room 204
Facilitators: Andrea Bezjak, Patrick Cheung, Rob MacRae, David
Palma, Anand Swaminath
Objectives: At the end of this session the learner will:
• become aware of different ways in which centers deal with
SBRT lung for lesions that is very close to a critical organ at
risk.
• reflect on the clinical and technical issues that may make a
patients with early stage NSCLC not a candidate for SBRT.
• have a better understanding of the issues related to
evaluation of radiological response after lung SBRT.
• consider what type of patient with oligometastatic disease
would be suitable for treatment with lung SBRT.
4.
Leadership Workshop – Developing Leaders of Excellence,
Succession Planning and Mentoring the Leaders of Tomorrow
Facilitators: Chandra Martens, Peter Craighead, Michael Lock,
Ross Halperin, Padraig Warde, Woodrow Wells, Ethan Lyn,
Mary Gospodarowicz
Room 103
Objectives: At the end of this session the learner will:
• hear from current key leaders and experts who have an
understanding of, and practical tools, to mentor and to
develop both new and existing leaders in our Oncology
centres.
• enhance succession planning, leadership development, and
encourage team building and positive working relationships
between multidisciplinary teams working together.
• be given practical advice and tools from the key medical
leaders, based on experience and research in succession
planning, and have these tools available to apply in their own
centres.
8:00-9:00
Canadian Brachytherapy Group Session
Room 206/208
Moderator: Gerard Morton
Objectives:
•
To review selected Canadian brachytherapy practices and
outcomes.
8:00-8:10
156
VALIDATION STUDY OF US-BASED HDR PROSTATE
BRACHYTHERAPY PLANNING COMPARED TO CT GOLD
STANDARD
Juanita Crook, Deidre Batchelar, Matt Schmid, Cynthia Araujo, MariePierre Milette, David Petrik, Francois Bachand, Miren Gaztanaga
University of British Columbia, Kelowna, BC
8:10-8:20
157
IMAGE GUIDED ADAPTATIVE BRACHYTHERAPY IN LOCALLY
ADVANCED CERVICAL CANCER - RESULTS OF A
MULTIINSTITUTIONAL DATA COLLECTION
1
2
2
Alina Sturdza , Lars Urlich Fokdal , Jacob Christian Lindegaard , Karen
1
1
2
1
Nkiwane , Christian Kirisits , Kari Tanderup , Richard Pötter ,
3
RetroEMBRACE Study Group
1
2
Medical University of Vienna, Vienna, Austria; Aarhus University,
3
Aarhus University, Denmark; Multi-institutional, Vienna, Paris, Aarhus,
Leuven, London, Ljubljana, Cambridge, Dublin, Chiang Mai, Mumbay,
Utrecht, Austria
8:20-8:30
158
A CANADIAN SURVEY OF INTRAUTERINE CERVIX
BRACHYTHERAPY FROM A PHYSICS PERSPECTIVE
Kristin Marchant, Evgeny Sadikov
University of Saskatchewan, Regina, SK
8:30-8:40
159
INTEGRATION OF CT-PLANNED INTERSTITIAL BRACHYTHERAPY
BOOST IN ADVANCED GYNECOLOGIC MALIGNANCIES
1
2
3
2
Ericka Wiebe , Kathleen Surry , Nikhilesh Patil , Simran Aulakh ,
2
2
3
Frances Whiston , Larry Stitt , David D'Souza
1
2
Odette Cancer Centre, Toronto, ON; University of Western Ontario,
3
London, ON; London Regional Cancer Program, London, ON
8:40-8:50
160
ULTRASOUND-CT FUSION COMPARED WITH MR-CT FUSION FOR
POST-IMPLANT DOSIMETRY IN PERMANENT PROSTATE
BRACHYTHERAPY
1
2
2
2
David Bowes , Juanita Crook , Cynthia Araujo , Miren Gaztanago ,
2
Deidre Batchelar
1
2
Nova Scotia Cancer Agency, Halifax, NS; British Columbia Cancer
Agency, Kelowna, BC
8:50-9:00
161
THE LONG TERM EXPERIENCE OF PERMANENT SEED IMPLANT
MONOTHERAPY IN LOW AND INTERMEDIATE RISK PROSTATE
CANCER
Eric Vineault, Ag Martin, W Foster, S Aubin, P Després, Luc Beaulieu
CHUQ, Quebec, QC
9:00-10:30
Oral Session 4 - Education and Survivorship
Room 206/208
Moderator: Chandra Martens
Objectives:
•
To review educational, supportive care and survivorship issues for
both Radiation Oncology professionals and their patients.
9:00-9:10
162
THE IMPACT OF UNDERGRADUATE EDUCATION IN RADIATION
ONCOLOGY
Ravinder Pandher, Theresa Trotter
University of Calgary, Calgary, AB
9:10-9:20
163
RADIATION ONCOLOGY RESIDENT WORKLOAD IN A CANADIAN
PROVINCE: ANALYSIS OF NEW PATIENT AND FOLLOW UP
DICTATION DATA
Eric Tran, Hannah Carolan, Robert Olson
British Columbia Cancer Agency, Vancouver, BC
9:20-9:30
164
THE UNIVERSITY OF TORONTO RADIATION ONCOLOGY
FELLOWSHIP PROGRAM: A SURVEY OF FELLOWS BETWEEN 19982008
1
2
2
2
Max Dahele , Zahra Kassam , Mary Gospodarowicz , Elena Gessas ,
2
Charles Catton
1
2
VU University Medical Center, Amsterdam, Netherlands; University of
Toronto, Princess Margaret Hospital, Toronto, ON
9:30-9:40
165
TRAINING THE “COMPLETE RADIATION ONCOLOGIST”:
INSTRUCTIONAL METHODS USED FOR CANMEDS TRAINING IN
CANADIAN RADIATION ONCOLOGY PROGRAMS
1
2
3
Paris-Ann Ingledew , Chandra Martens , Tamara Shenkier , Sonia Kim
1
Anh Nguyen
2
1
University of British Columbia, Surrey, BC; McGill University, Gatineau,
3
QC; University of British Columbia, Vancouver, BC
9:40-9:50
166
MEETING THE INFORMATIONAL NEEDS OF ONCOLOGY PATIENTS
THROUGH THE INNOVATIVE USE OF INFORMATION TECHNOLOGY
– ARE WE READY YET?
Larry Pan, Gwen MacDonald, Judy Hale, Liz Dobbin, Ethan Laukkanen
PEI Cancer Treatment Centre, Charlottetown, PE
9:50-10:00
167
RESULTS OF A CLUSTER RANDOMIZED TRIAL OF AN EARLY
NURSING INTERVENTION TO IMPROVE SUPPORIVE CARE FOR
BREAST AND COLORECTAL CANCER PATIENTS
1
2
3
Jonathan Sussman , Daryl Bainbridge , Doris Howell
1
2
Juravinski Cancer Centre, Hamilton, ON; McMaster University,
3
Hamilton, ON; University of Toronto, Toronto, ON
10:00-10:10
168
PALLIATIVE RADIOTHERAPY (RT) IN PATIENTS WITH POOR
PERFORMANCE STATUS - SHOULD WE TAILOR OUR TREATMENT?
Chris Fosker, Tony Panzarella, Shawde Harris, Anthea Lau, Michelle
Lau, Corsita Garraway, Micheal McLean, Wilfred Levin, Andrea Bezjak,
Rebecca KS Wong
Princess Margaret Hospital, Toronto, ON
10:10-10:20
169
CHILDHOOD CANCER SURVIVORS’ PERSPECTIVES AND
PREFERENCES FOR LONG-TERM MEDICAL FOLLOW-UP
1
1
2
2
Karen Goddard , Rob Olson , Gabe Hung , Fuchsia Howard
1
2
British Columbia Cancer Agency, Vancouver, BC; University of British
Columbia, Vancouver, BC
10:20-10:30
170
HEALTH INDICATORS IN THE RADIOTHERAPY WORKPLACE
Geneviève Coulombe, Dominique Lefebvre, Daniel Payette, Michèle De
Guise, Danielle Daunais, Amélie Ouellette, Jean-Pierre Guay, David
Roberge
CHUM, Montréal, QC
9:00-10:40
Oral Session 5 Clinical - Lung and CNS
Room 205/207
Holly Campbell, Liam Mulroy
Objectives:
• To review response to radiation and treatment outcomes in selected
Canadian cancer centres.
9:00-9:10
171
A PHASE II STUDY OF ACCELERATED HYPOFRACTIONATED 3DIMENSIONAL CONFORMAL RADIOTHEARPY FOR INOPERABLE
T1-3 N0 M0 NON-SMALL CELL LUNG CANCER: NCIC CTG BR.25
1
2
3
4
Patrick Cheung , Sergio Faria , Shahida Ahmed , Pierre Chabot ,
5
6
7
Jonathan Greenland , Elizabeth Kurien , Islam Mohamed , James
8
9
9
Wright , Keyue Ding , Chris O'Callaghan
1
2
Odette Cancer Centre, Toronto, ON; McGill University, Montreal, QC;
3
4
Cancer Care Manitoba, Winnipeg, MB; Hopital Maisonneuve5
Rosemont, Montreal, QC; Dr. H. Bliss Murphy Cancer Centre, St John's,
6
7
NL; Tom Baker Cancer Centre, Calgary, AB; British Columbia Cancer
8
Agency, Kelowna, BC; Juravinski Cancer Centre, Hamilton, ON;
9
Queen's University, Kingston, ON
9:10-9:20
172
DIFFERENTIATING RADIATION FIBROSIS FROM TUMOUR
RECURRENCE AFTER STEREOTACTIC ABLATIVE RADIOTHERAPY
(SABR) FOR LUNG CANCER: THE IMPACT OF CT-BASED IMAGE
TEXTURE ANALYSIS
1
1
2
Sarah Mattonen , Aaron D. Ward , Cornelis J. A. Haasbeek Suresh
2
3
Senan , David Palma
1
2
University of Western Ontario, London, ON; VU University Medical
3
Center, Amsterdam, Netherlands; London Regional Cancer Program,
London, ON
9:20-9:30
173
NTCP MODELING OF RADIOGRAPHIC CHANGES IN NORMAL LUNG
TISSUE IN PATIENTS TREATED WITH CONVENTIONAL AND
HYPOFRACTIONATED RADIATION THERAPY
1
2
3
4
David Palma , Quentin Diot , Suresh Senan , Michael Lawrence , Soren
5
2
4
2
Bentzen , Brian Kavanagh , Lawrence Marks , Moyed Miften
1
2
London Regional Cancer Program, London, ON; University of Colorado
3
School of Medicine, Aurora, CO; VU University Medical Center,
4
Amsterdam, Netherlands; University of North Carolina, Chapel Hill, NC;
5
University of Wisconsin, Madison, WI
9:30-9:40
174
METFORMIN ENHANCES RADIATION RESPONSES IN NON-SMALL
CELL LUNG CANCER (NSCLC)
1
1
1
2
Yaryna Storozhuk , Sarah Hopmans , Toran Sanli , Carly Barron ,
2
3
3
1
Evangelia Tsiani , Carrie Thomas Farrell , Schultz , Jean-Claude Cutz ,
4
1
1
1
Robert Bristow , James Wright , Gurmit Singh , Theodoros Tsakiridis
1
2
McMaster University, Hamilton, ON; Brock University, St. Catharines,
3
4
ON; Juravinski Cancer Centre, Hamilton, ON; University of Toronto,
Toronto, ON
9:40-9:50
175
LUNG TUMOUR TRACKING: LESSONS LEARNED TREATING OUR
FIRST 200 CYBERKNIFE PATIENTS
Houda Bahig, Edith Filion, Marie-Pierre Campeau, Robert Doucet,
Dominic Béliveau Nadeau, Louise Lambert, Toni Vu, David Roberge
Centre Hospitalier de l'Université de Montréal, Montréal, QC
9:50-10:00
176
A RANDOMIZED COMPARISON OF LUNG STEREOTACTIC BODY
RADIATION THERAPY (SBRT) DELIVERED OVER 4 OR 11 DAYS –
ACUTE TOXICITY AND QUALITY OF LIFE
1
1
1
1
2
Suneil Jain , Patrick Cheung , Ian Poon , Brian Keller , Hany Soliman ,
1
Fiona Lochray
1
2
Odette Cancer Centre, Toronto, ON; Carlo Fidani Peel Regional
Cancer Centre, Mississauga, ON
10:00-10:10
177
CORRELATION OF HIGH-GRADE GLIOMA RELAPSE VOLUMES
WITH RADIOTHERAPY TARGET VOLUMES DELINEATED USING
18F-FDOPA PET TRACER UPTAKE
1
1
2
1
1
Elisa K. Chan , Robert Kosztyla , Fred Hsu , Don Wilson , Roy Ma ,
2
1
1
1
Arthur Cheung , Vitali Moiseenko , Susan Zhang , Francois Benard ,
1
Alan Nichol
1
2
British Columbia Cancer Agency, Vancouver, BC; British Columbia
Cancer Agency, Abbotsford, BC
10:10-10:20
178
FINAL RESULTS OF A PROSPECTIVE TRIAL EVALUATING
ACCELERATED RADIATION THERAPY USING TOMOTHERAPY
SIMULTANEOUS INTEGRATED BOOST (ARTOSIB) WITH
CONCURRENT AND ADJUVANT TEMOZOLOMIDE (TMZ)
CHEMOTHERAPY IN THE TREATMENT OF GLIOBLASTOMA
MULTIFORME (GBM)
1
1
2
Jean-Michel Caudrelier , Hussain AlHussain , Shawn Malone , Stan
1
2
1
1
2
Gertler , Thanh Nguyen , Garth Nicholas , Nancy Page , John Woulfe ,
1
Olugesun Agboola , Lynn Montgomery
1
2
Ottawa Hospital Regional Cancer Centre, Ottawa, ON; The Ottawa
Hospital, University of Ottawa, ON
10:20-10:30
179
BOOST VERSUS SALVAGE RADIOSURGERY FOR BRAIN
METASTASES AFTER WHOLE BRAIN RADIOTHERAPY
1
2
2
3
Fred Hsu , Sonia Nguyen , Arthur Cheung , Michael McKenzie , Roy
3
3
Ma , Alan Nichol ,
1
2
British Columbia Cancer Agency, Abbotsford, BC; British Columbia
3
Cancer Agency, Surrey, BC; British Columbia Cancer Agency,
Vancouver, BC
10:30-10:40
180
PHASE I DOSE ESCALATION STUDY OF SUNITINIB AND
RADIOSURGERY FOR BRAIN METASTASES
Caroline Chung, Cynthia Menard, Christiaan Stevens, Normand
Laperriere, Barbara-Ann Millar,
Mark Bernstein, Gelareh Zadeh, Warren Mason, Anthony Brade
University of Toronto, Toronto, ON
10:30-11:00
Break
11:00-12:30
CARO-ESTRO Symposium
Frontiers in Radiation Biology: The Next Decade
Room 205-208
Moderators: Andrea Bezjak, Fabio Cury
Challenges and Opportunities in Developing RT and Targeted Therapy
Protocols
Donal Hollywood
Integrating Genomics into Clinical Practice
Robert Bristow
Case/Panel Discussion
Panelists: Donal Hollywood, Robert Bristow, Anne Hansen Ree
Objectives:
• To provide an interactive symposium addressing clinical application
of targeted therapy from the European and Canadian viewpoint.
12:30-12:45
Break
12:45-2:00
People’s Choice
Room 205-208
Moderator: Ross Halperin
Objectives:
• To highlight exemplary Canadian-led research in Radiation
Oncology.
12:45-1:00
181
RADIUM-223 CHLORIDE (ALPHARADIN) IMPROVES OVERALL
SURVIVAL
Shawn Malone, E Leung, Libni Eapen, J Garcia-Vargas, Chris Parker
University of Ottawa, Ottawa, ON
1:00-1:15
182
PHASE II TRIAL OF NEO-ADJUVANT TEMOZOLOMIDE (TMZ)
FOLLOWED BY CONCURRENT TMZ AND HYPOFRACTIONATED
ACCELERATED EXTERNAL BEAM RADIOTHERAPY (AC-EBRT) AND
ADJUVANT TMZ FOR PATIENTS WITH GLIOBLASTOMA
MULTIFORME (GBM): PRELIMINARY RESULTS
George Shenouda, Luis Souhami, Valerie Panet-Raymond, Bassam
Abdulkarim, Fabio Cury, Scott Owen, Kevin Petrecca, Marie-Christine
Guiot, Petr Kavan, Rolando DelMaestro, Richard Leblanc
McGill University, Montreal, QC
1:15-1:30
183
POST-MENOPAUSAL WOMEN WITH LUMINAL A SUBTYPE MIGHT
NOT REQUIRE BREAST RADIOTHERAPY – PRELIMINARY RESULTS
FROM A RANDOMIZED CLINICAL TRIAL OF TAMOXIFEN +
RADIATION
1
2
3
2
Lorna Weir , Anthony Fyles , Willa Wei Shi , Melania Pintilie , Susan
2
2
3
4
5
Done , Naomi Miller , Derek Wong , Ivo Olivotto , Maureen Trudeau ,
2
2
David McCready , Fei-Fei Liu
1
2
British Columbia Cancer Agency, Vancouver, BC; Princess Margaret
Hospital, Toronto, ON;
3
4
Ontario Cancer Institute, Toronto, ON; British Columbia Cancer
5
Agency, Victoria, BC; Odette Cancer Centre, Toronto, ON
1:30-1:45
184
THE IMPACT OF RADIOTHERAPY (RT) ON QUALITY OF LIFE (QOL)
WHEN GIVEN IN COMBINATION WITH ANDROGEN DEPRIVATION
THERAPY (ADT) FOR LOCALLY ADVANCED PROSTATE CANCER:
QOL RESULTS FROM NCIC CTG PR3 / MEDICAL RESEARCH
COUNCIL MRC PR07 RANDOMIZED TRIAL
1
2
2
3
Michael Brundage , Wendy Parulekar Bingshu Chen , Andrea Bezjak ,
4
5
2
3
Matthew Sydes , Malcom Mason , Andrea Hiltz , Padraig Warde
1
2
Cancer Centre of Southern Ontario, Kingston, ON; NCIC CTG,
3
4
Kingston, ON; Princess Margaret Hospital, Toronto, ON; MRC Clinical
5
Trials Unit, London, United Kingdom; Cardiff University School of
Medicine, Cardiff, United Kingdom
1:45-2:00
185
FINAL ANALYSIS OF INTERGROUP RANDOMISED PHASE III STUDY
OF ANDROGEN DEPRIVATION THERAPY (ADT) +/- RADIATION
THERAPY (RT) IN LOCALLY ADVANCED PROSTATE CANCER
(NCIC-CTG, SWOG, MRC-UK, INT: T94-0110; NCT00002633)
1
2
3
4
Padraig Warde , Wendy Parulekar , Max Parmar , John Anderson , John
5
6
2
7
Barber , Michael Brundage , Bingshu Chen , Richard Cowan , Mary
1
8
9
2
Gospodarowicz , Charles Hayter , John Hetherington , Andrea Hiltz ,
4
10
3
11,
Peter Kirkbride , Edward Kostashuk , Karen Sanders , Jinka Sathya
12
3
13
Gregory Swanson , Mathew Sydes , Malcolm Mason
1
2
Princess Margaret Hospital, Toronto, ON; NCIC CTG, Kingston, ON;
3
4
MRC Clinical Trials Unit, London, United Kingdom; Weston Park
5
Hospital, Sheffield, United Kingdom; Velindre Hospital, Cardiff, United
6
7
Kingdom; Kingston Regional Cancer Center, Kingston, ON; Christie
8
Hospital, Manchester, United Kingdom; Carlo Fidani Cancer Center,
9
10
Mississauga, ON; Castle Hill Hospital, Hull, United Kingdom; Fraser
11
Valley Cancer Centre, Surrey, BC; H Bliss Murphy Cancer Clinic, St
12
John's, NL; University of Texas Health Sciences Center, San Antonio,
13
TX; Cardiff University, Cardiff, United Kingdom
2:00
Closing Remarks
Ross Halperin
Chandra Martens
POSTER ABSTRACTS
186
ADJUVANT RADIOTHERAPY IMPROVES LOCAL CONTROL AND SURVIVAL IN PATIENTS
WITH UTERINE LEIOMYOSARCOMA
Philip Wong, Kathy Han, Jenna Sykes, Charles Catton, Stephane Laframboise, Anthony Fyles,
Lee Manchul, Wilfred Levin, Michael Milosevic
University of Toronto, Toronto, ON
187
GRADE OF TOXICITY IN IMMUNOSUPPRESSED PATIENTS FOLLOWING RADIATION
THERAPY FOR PRIMARY HEAD AND NECK CANCER
Rania Hashem, Fabio Cury, McGill, Karen Kost, Anthony Zeitouni, George Shenouda
McGill University Health Centre, Montreal, QC
188
A METHODOLOGY FOR THE EARLY DETECTION OF NON-SMALL CELL LUNG CANCER
USING MIRNA PROFILING IN SPUTUM
1
1
2
1
1
3
Wilson Roa , Rene Razzak , Hongfei Du , Linghong Guo , Ravinder Singh , Sayf Gazala , Julian
1
1
3
3
3
Kim , Sunita Ghosh , Eric Wong , Eric Bedard , James Xing
1
2
Cross Cancer Institute, Edmonton, AB; University of Electronic Science and Technology,
3
Chengdu, Chengdu, China; University of Alberta, Edmonton, AB
189
OPTIMAL STRATEGY FOR PROPHYLACTIC CRANIAL IRRADIATION IN LIMITED STAGE
SMALL CELL LUNG CANCER
1
2
3
4
Patricia Tai , Avi Assouline , Kurian Joseph , Edward Yu
1
2
Allan Blair Cancer Centre, Regina, SK; Centre Clinique de la Porte de Saint Cloud, Boulogne,
3
4
France; University of Alberta, Edmonton, AB; University of Western Ontario, London, ON
190
SHOULD RADIATION THERAPY BE OFFERED TO NONAGENARIANS?
Jean Archambault
Université Laval, Québec, QC
191
PILOT INTERDISCIPLINARY PALLIATIVE LUNG RAPID ACCESS RADIOTHERAPY CLINIC –
EXPERIENCES, PERCEPTIONS, AND GOALS
Shilo Lefresne, Karen Levy, Rosemary Cashman, Robert Olson
British Columbia Cancer Agency, Vancouver, BC
192
RELATIONSHIPS BETWEEN FAMILY PHYSICIANS TESTED KNOWLEDGE, SELFPERCEIVED KNOWLEDGE, AND UTILIZATION OF PALLIATIVE RADIOTHERAPY
Robert Olson, Sonca Lengoc, John French, Colleen McGahan, Scott Tyldesley, Jenny Soo
British Columbia Cancer Agency, Vancouver, BC
193
IMPLEMENTATION AND EARLY EVALUATION OF LINAC IMRT FOR THE POST OPERATIVE
LOCOREGIONAL RADIATION OF BREAST CANCER
1
2
3
2
2
Sara Samiee , Manon Lacelle , Balazs Nyiri , Nicolas Ploquin , Jean-Michel Caudrelier
1
2
3
University of Ottawa, Ottawa, ON; Ottawa Hospital Cancer Centre, Ottawa, ON; The Ottawa
Hospital, Ottawa, ON
194
THE “CSRT EFFECT”: IMPLEMENTING ADVANCED PRACTICE INTO A BONE AND BRAIN
METASTASES CLINIC
1
1
1
2
1
Julie Blain , Laura Zychla , Marcia Smoke , Nicole Harnett , William McMillan
1
2
McMaster University, Hamilton, ON; University of Toronto, Toronto, ON
195
CLINICAL OUTCOMES AFTER SALVAGE RADIOSURGERY FOR BRAIN METASTASES
Goldie Kurtz, Gelareh Zadeh, Genevieve Gingras-Hill, Barbara-Ann Millar, Normand Laperriere,
Mark Bernstein, Cynthia Menard, Caroline Chung
University of Toronto, Toronto, ON
196
SEED MIGRATION IN PROSTATE BRACHYTHERAPY DEPENDS ON EXPERIENCE AND
TECHNIQUE
Guila Delouya, Daniel Taussky, Camille Moumdjian, Renée Larouche, Dominic Béliveau-Nadeau,
Chantal Boudreau, Yannick Hervieux, David Donath
CHUM-Hôpital Notre-Dame, Montreal, QC
197
PATTERNS OF FAILURE FOLLOWING INTRA-OPERATIVE PROSTATE BRACHYTHERAPY
AT 8.5 YEARS USING INTRA-OPERATIVE INVERSE PLANNING AND AN AUTOMATED
DELIVERY SYSTEM
Siraj Husain, Steve Angyalfi, Michael Sia
Tom Baker Cancer Centre, Calgary, AB
198
DIMINISHING BENEFITS OF BREATH HOLD TECHNIQUE WITH BREAST CONSERVING
THERAPY
1
1
1
2
2
Angela Lin , Waseem Sharieff , Jim Whelan , Joe Szabo , Chris DiFranscisco , Michelle
2
2
1
Finucane , Julie Chase , Do-Hoon Kim
1
2
McMaster University, Hamilton, ON; Juravinski Cancer Centre, Hamilton, ON
199
INTERSTITIAL BRACHYTHERAPY AND LOCAL RESECTION FOR RECTAL CANCER IN 70
PATIENTS
1
2
3
Laval Grimard , Hartley Stern , Robin Boushey
1
2
The Ottawa Hospital Cancer Centre, Ottawa, ON, McGill University, Montreal, QC,
3
Université d'Ottawa, Ottawa, ON
200
HYPOFRACTIONATION IN PROSTATE CANCER: LEARNING WHEN THE "SAME DOSE" CAN
LEAD TO DIFFERENT TOXICITY
Sergio Faria, Luis Souhami, Russel Ruo, James Coates, Issam El Naqa
McGill University, Montreal, QC
201
ROLE OF PALLIATIVE RADIATION THERAPY FOR SPINAL CORD COMPRESSION DUE TO
METASTATIC MALIGNANT MELANOMA
1
2
3
1
Isabelle Thibault , Marc Gaudet , Philippe Després , Anne Dagnault
1
2
3
CHUQ, L'Hôtel-Dieu de Québec, Québec, QC; Hôpital de Gatineau, Gatineau, QC ; Université
Laval, Québec, QC
202
IMPROVING WAIT TIMES FOR RADIOTHERAPY BY SHORTENING THE WAIT FOR
SIMULATION VISITS
1
2
3
4
Monica Behl , Sheila Coulter , Diane Treppel , Renee Belitski
1
2
Allan Blair Cancer Centre, Regina, SK; Saskatoon Cancer Centre, Saskatoon, SK;
3
Saskatchewan Cancer Agency, Saskatoon, SK; 4Saskatchewan Cancer Agency, Regina, SK
203
CHOROIDAL METASTASES IN BREAST CANCER: OUTCOMES OF A POPULATION-BASED
COHORT
Jeffrey Cao, Scott Tyldesley, Hannah Carolan, Ryan Woods, Caroline Speers, Robert Olson
University of British Columbia, Vancouver, BC
204
EVALUATION OF DEFORMABLE REGISTRATION SOFTWARE FOR BIOLOGICALLY
EQUIVALENT DOSE (BED) SUMMATION AND ANALYSIS IN SPINE RE-IRRADIATION
Anoop Haridass, Janet Hendry, Lesley Buckley, Shawn Malone
University of Ottawa, Ottawa, ON
205
TREATMENT AND PLANNING CHALLENGES OF A DOSE ESCALATION TRIAL OF MULTIPLE
MYELOMA PATIENTS BY TREATING TOTAL MARROW USING TOMOTHERAPY
Lynn Montgomery, Larry Atkins, Lee Gerig, Kathy Carty, Gosia Niedbala, Balazs Nyiri, Rajiv
Samant
University of Ottawa, Ottawa, ON
206
AN ELEGANT SOLUTION TO RTOG 0933
Joe Andreas, Vijayanda Kundapur, Gavin Cranmer-Sargison
University of Saskatchewan, Saskatoon, SK
207
IMPACT OF RADICAL PROSTATECTOMY ON RECTAL POSITION AND IMPLICATIONS FOR
CTV DEFINITION FOR POST-OPERATIVE PROSTATE RADIATION
1
2
2
2
2
2
Jennifer Croke , Balazs Nyiri , Len Avruch , Eric Belanger , Chris Morash , Shawn Malone
1
2
University of Ottawa, Ottawa, ON; The Ottawa Hospital, Ottawa, ON
208
THE USE OF ARRAY COMPARATIVE GENOMIC HYBRIDIZATION (ACGH) IN THE
DEVELOPMENT OF PERSONALIZED APPROACHES TO PROSTATE CANCER THERAPY
1
1
1
2
2
Robert Bristow , Adrian Ishkanian , Gaetano Zafarana , Jennifer Locke , Alice Meng , Chad
3
3
1
2
2
4
Maloff , Wan Lam , Michael Fraser , Colin Collins , Stanislav Volik , Lakshmi Muthuswamy ,
4
4
4
5
4
John McPherson , Thomas Hudson , Lincoln Stein , Theodorus van der Kwast , Paul Boutros
1
2
Princess Margaret Hospital, Toronto, ON; STTARR Innovation Program, Toronto, ON;
3
3
STTARR Innovation Program, Toronto, ON; University of British Columbia, Vancouver, BC;
4
5
Ontario Institute for Cancer Research, Toronto, ON; University Health Network, Toronto, ON
209
IS RADIATION THERAPY WITH CETUXIMAB AN EFFECTIVE TREATMENT IN HUMAN
PAPILLOMA VIRUS POSITIVE LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL
CANCER
Allison Chew, Cheryl Ho, Jonn Wu,
British Columbia Cancer Agency, Vancouver, BC
210
THE IMPACT OF RESPIRATORY GATING ON TOXICITY OUTCOMES FOR LOCALLY
ADVANCED LUNG CANCER TREATED WITH RADICAL CHEMORADIOTHERAPY
Stephanie M. Casey, Alexander V. Louie, George Rodrigues, David Palma, Brian Yaremko, A.
Rashid Dar, Edward Yu, Inge Aivas, Andrew Warner, Stewart Gaede
London Regional Cancer Program, London, ON
211
STEREOTACTIC LUNG RADIOTHERAPY: OUTCOMES AND TOXICITY OF VARIOUS DOSE
REGIMENS USED AT THE MCGILL UNIVERSITY HEALTH CENTRE
1
2
2
2
2
Lily Shakibnia , Bassam Abdulkarim , Issam El Naqa , Sergio Faria , Neil Kopek , Emily
2
2
Soisson , Jonathan Wan
1
2
McGill University Health Centre, Montreal, QC; McGill University, Montreal, QC
212
IS THERE A DETRIMENT TO DELIVERING THORACIC RADIOTHERAPY OVER >19 DAYS IN
LIMITED-STAGE SMALL CELL LUNG CANCER?
1
2
3
2
Eric Tran , Cheryl Alexander , Devin Schellenberg , Elaine Wai
1
2
British Columbia Cancer Agency, Vancouver, BC; British Columbia Cancer Agency, Victoria,
3
BC; British Columbia Cancer Agency, Surrey, BC
213
OUTCOME OF STAGE I NON-SMALL CELL LUNG CANCER AFTER STEREOTACTIC BODY
RADIATION THERAPY, DOES GROWTH RATE MATTER?
Soha Atallah, Andrea Bezjak, Mojgan Taremi, Zishan Allibhai, Lisa Le, Alexander Sun, Anthony
Brade, John Cho, Andrew J Hope
University of Toronto, Toronto, ON
214
PHOTODYNAMIC THERAPY FOR BOWEN’S DISEASE OF THE PENIS
1
2
1
1
1
1
Alexander Louie , Justin Chia , Kevin Jordan , Jim Gilchrist , Barbara Fisher , David D'Souza
1
2
London Regional Cancer Program, London, ON; University of Western Ontario, London, ON
215
TRANSIENT TUMOUR VOLUME INCREASE IN VESTIBULAR SCHWANNOMAS AFTER
RADIOTHERAPY
1
2
2
2
2
Lara Hathout , Carole Lambert , Jean-François Carrier , Jean-Paul Bahary , Yannick Hervieux ,
2
2
2
Robert Moumdjian , Marie-Andrée Fortin , David Roberge
1
2
Université de Montréal, Montreal, QC ; Centre hospitalier de l'Université de Montréal, Montreal,
QC
216
TECHNIQUE FOR USING DYNAMIC CT ANGIOGRAPHY (DCTA) FOR FRAMELESS
STEREOTACTIC RADIOSURGICAL (SRS) PLANNING OF INTRACRANIAL ARTERIO VENOUS
MALFORMATIONS (AVM)
Anoop Haridass, Santanu Chakraborty, Robert Chatelain, Janos Szanto, Cheemun Lum, Shawn
Malone, John Sinclair
The Ottawa Hospital, Ottawa, ON
217
FIDUCIAL MARKERS (FM) IN THE PROSTATE BED FOR POST PROSTATECTOMY
EXTERNAL BEAM RADIATION THERAPY: IMPROVED ACCURACY AS COMPARED TO THE
USE OF SURGICAL CLIPS
Israël Fortin, Jean-François Carrier, Marie-Claude Beauchemin, Dominic Béliveau-Nadeau,
Guila Delouya, Daniel Taussky
Université de Montréal, Montréal, QC
218
DOSIMETRY AND COST-EFFECTIVENESS COMPARATIVE ANALYSIS BETWEEN VOLUME
MODULATED ARC THERAPY (VMAT) AND HELICAL TOMOTHERAPY (HT) IN TREATMENT
OF GLIOBLASTOMA MULTIFORME (GBM) USING ACCELERATED RADIATION THERAPY
WITH SIMULTANEOUS INTEGRATED BOOST (ARTOSIB)
Hussain Al Hussain, Robert Zohr, Jean-Michel Caudrelier, Shawn Malone
University of Ottawa, Ottawa, ON
219
“I’M NO TEACHER”: EXPLORING THE PERCEPTION OF RADIATION THERAPISTS IN
ASSESSING CLINICAL COMPETENCE OF UNDERGRADUATE STUDENTS WITHIN AN
ACADEMIC CLINICAL SETTING
1
2
1
Kieng Tan , Krista Dawdy , Lisa Di Prospero
1
2
University of Toronto, Toronto, ON; Sunnybrook Health Sciences Centre, Toronto, ON
220
RADIOTHERAPY FOR CERVIX CANCER: ARE WE REALLY IMPROVING OUTCOMES?
1
1
1
2
1
1
Sofya Kobeleva , Rajiv Samant , Choan E , Khalid Balaraj , Tien Le , Michael Fung-Kee-Fung
1
2
University of Ottawa, Ottawa, ON; Tawam Hospital, Al Ain, United Arab Emirates
221
RETROSPECTIVE COMPARISON OF TWO FEEDING TUBE APPROACHES FOR HEAD &
NECK CANCER PATIENTS RECEIVING CONCURRENT CHEMO-RADIATION THERAPY
1
2
1
3
1
Irene Karam , Gavin Wilson , Angela Bowman , Frances Wong , Robert Olson
1
2
British Columbia Cancer Agency, Vancouver, BC; University of British Columbia, Vancouver,
3
BC; British Columbia Cancer Agency, Fraser Valley Centre, Surrey, BC
222
COMPARISON OF 3D CONFORMAL RADIOTHERAPY (3DCRT) AND INTENSITY
MODULATED RADIOTHERAPY (IMRT) IN STAGE III NON SMALL CELL LUNG CANCER
(NSCLC)
Paula McCloskey, Soha Atallah, Linda Coate, Alisha Albert-Green, Tom Purdie, Andrew Hope,
John Cho, Anthony Brade, Alexander Sun, Frances Shepherd, Andrea Bezjak
Princess Margaret Hospital, Toronto, ON
223
BREAST CANCER SURVIVORSHIP CARE TAILORED TO SOUTH ASIAN WOMEN
1
2
1
Sonia Kim Anh Nguyen , Savitri Singh-Carlson , Frances Wong
1
2
British Columbia Cancer Agency, Fraser Valley Centre, Surrey, BC; California State University,
Long Beach, CA
224
BREAST CANCER CARE NAVIGATION IN RURAL SETTINGS: FEASIBILITY STUDY OF A
SYSTEMS-LEVEL APPROACH
1
2
1
Dan Le , Heather Wozney , Robert Olson
1
2
University of British Columbia, Vancouver, BC; University Hospital of Northern British Columbia,
Prince George, BC
0225
SUBCLINICAL MALIGNANT SPINAL CORD COMPRESSION – A MORE FAVORABLE
ENTITY?
1
1
2
2
1
1
Chris Fosker , Lisa Wang , Shawde Harris , Michelle Lau , Wilfred Levin , Michael McLean ,
1
2
1
Andrea Bezjak , Raja Rampersaud , Rebecca Wong
1
2
University of Toronto, Toronto, ON; Princess Margaret Hospital, Toronto, ON
0226
OPINIONS FROM THE EXPERTS: WHAT PROSTATE CANCER PATIENTS SHOULD KNOW
ABOUT POST-OPERATIVE RADIOTHERAPY
1
2
3
3
3
Laura D’Alimonte , Deb Feldman-Stewart , Arlene Court , Margaret Fitch , Lisa Di Prospero ,
3
3
3
John Maamoun , Alex Kiss , Ewa Szumacher
1
2
3
Odette Cancer Centre, Toronto, ON; Queen's University, Kingston, ON; University of Toronto,
Toronto, ON
227
TANGLED IN THE BREAST CANCER WEB: AN EVALUATION OF THE USAGE OF WEBBASED INFORMATION RESOURCES BY BREAST CANCER PATIENTS
Sonia Kim Anh Nguyen, Paris-Ann Ingledew
British Columbia Cancer Agency, Surrey, BC
228
CLINICAL OUTCOME OF PATIENTS WITH STAGE I ENDOMETRIAL CANCER: A SINGLE
INSTITUTION EXPERIENCE
Saif Althaqfi, Rajiv Samant, Choan E, Krystine Lupe, Ian Bambury
University of Ottawa, Ottawa, ON
229
SUV STABILITY IN PRIMARY HEAD AND NECK CANCER: PRE- AND INTRA- TREATMENT
FDG-PET/CT ANALYSIS
Tatiana Conrad, Benjiman Smith, Andrew Brotherston, Ian Poon
University of Toronto, Toronto, ON
230
THE UTILIZATION OF IMRT PLANNING IN DECREASING THE RISK OF ACCELERATED
DEMYELINATION IN MULTIPLE SCLEROSIS PATIENTS FOLLOWING EXTERNAL BEAM
RADIATION THERAPY
Rania Hashem, William Parker, Fabio Cury, Khalil Sultanem, William Tong, George Shenouda
McGill University Health Centre, Montreal, QC
231
MULTIDISCIPLINARY PREDICTION OF SURVIVAL IN ADVANCED CANCER PATIENTS
Brock Debenham, Brita Danielson, Fleur Huang, Sunita Ghosh, Alysa Fairchild
University of Alberta, Edmonton, AB
232
TEMPLATE-BASED BREAST IMRT PLANNING FOR INCREASED WORKLOAD EFFICIENCY
Sonia Kim Anh Nguyen, Fred Cao, Sarah Kristensen, Peter Steiner, Craig Elith, Winkle Kwan
British Columbia Cancer Agency, Surrey, BC
233
PERMANENT SEED BRACHYTHERAPY FOR LOCALLY RECURRENT PRSOTATE CANCER
FOLLOWING RADICAL PROSTATECTOMY: A CASE REPORT
David Bowes1, Juanita Crook2, Miren Gaztanaga2
1Nova Scotia Cancer Agency, Halifax, NS; 2British Columbia Cancer Agency, Kelowna, BC
234
4D MONTE CARLO CALCULATIONS OF VMAT AND HELICAL TOMOTHERAPY DOSE
DISTRIBUTIONS OF LUNG STEREOTACTIC TREATMENTS WITH INTRA-FRACTION
MOTION
Jason Belec, Brenda Clark,
Carleton University, Ottawa, ON
235
MULTIDISCIPLINARY MANAGEMENT OF CANCER PATIENTS: ARE WE CHASING OUR
SHADOW OR ARE THEY OF REAL VALUE?
1
2
Jennifer Croke , Samy El-Sayed
1
2
University of Ottawa, Ottawa, ON; The Ottawa Hospital, Ottawa, ON
236
OMISSION OF A BOLUS IN POST-MASTECTOMY PATIENTS TREATED BY ADJUVANT
RADIOTHERAPY: RECURRENCE-FREE AND OVERALL SURVIVALS.
1
2
2
1
Melanie Letourneau , Jean-Charles Hogue , Christine Desbiens , Valérie Théberge
1
2
CHUQ, L'Hôtel-Dieu de Québec, Quebec, QC ; CHA Universitaire de Québec, Pavillon StSacrement, Quebec, QC
237
RETROSPECTIVE ANALYSIS OF EARLY STAGE NON-SMALL CELL LUNG CANCER
TREATED WITH AN HYPOFRACTIONATED COURSE OF RADIATION THERAPY
Marc-Emile Plourde, Michael Brundage, Timothy Owen
Queen's University, Kingston, ON
238
MINIMAL CLINICALLY MEANINGFUL DIFFERENCE IN THE EORTC QLQ-C30 AND QLQBM22 IN PATIENTS WITH BONE METASTASES
1
1
1
2
3
4
Luluel Khan , Liang Zeng , Lying Zhang , Ling-Ming Tseng , Ming-Feng Hou , Alysa Fairchild ,
5
6
7
Vassilios Vassiliou , Reynaldo Jesus-Garcia , Mohamed A. Alm El-Din , Rapid Response
8
Radiotherapy Program
1
2
3
University of Toronto, Toronto, ON; National Yang-Ming University, Taipei, Taiwan; Kaohsiung
4
Medical University Hospital, Kaohsiung, Taiwan; Cross Cancer Institute, Edmonton, AB;
5
6
7
Nicosia, Cyprus; Federal University of Sao Paulo, Sao Paulo, Brazil; Tanta University Hospital,
8
Tanta, Egypt; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto,
Toronto, ON
239
HER2 AND BASAL LIKE SUBTYPES OF INVASIVE BREAST CANCER ARE ASSOCIATED
WITH A HIGHER TUMOUR GRADE AND RATE OF LYMPH NODE METASTASIS
Xingrao Wu
McGill University, Montreal, QC
240
FOSTERING A NO-BLAME CULTURE: IMPLEMENTATION OF A LEARNING SERIES TO
EDUCATE RADIATION THERAPISTS ON THE QUALITY ASSURANCE PROGRAM AT A
LARGE COMPREHENSIVE CANCER CENTRE
Brian Liszewski, Lisa Di Prospero, Anne Wighton
University of Toronto, Toronto, ON
241
THE JUNIOR DOCTORS NETWORK OF THE WORLD MEDICAL ASSOCIATION: THE
WORLD’S FIRST INTERNATIONAL REPRESENTATIVE BODY FOR POSTGRADUATE
MEDICAL TRAINEES
1
2
3
3
4
Jean-Marc Bourque , Thorsten Hornung , Adam Kaufman , Lawrence Loh , Rob Mitchell , Will
5
6
Perry , Xaviour Walker
1
2
3
London Regional Cancer Program, London, ON; Bonn University, Bonn, Germany; University
4
of Toronto, Toronto, ON; Australian Medical Association Council for Doctors-in-Training, St
5
6
Barton, Australia; Harvard University, Cambridge, MA; Harvard Medical School, Cambridge, MA
242
INVESTIGATION OF A THERMOPLASTIC MASK SYSTEM FOR HEAD AND NECK CANCER
(HNC) RADIATION THERAPY: DO FORMAL TRAINING SESSIONS FOR RADIATION
THERAPISTS’ (RTS) IMPACT MASK FITTING AND ISOCENTRE REPRODUCIBILITY?
Angela Turner, Francois Gallant, Lisa DiProspero, Ananth Ravi, Tammy Lui
University of Toronto, Toronto, ON
243
IS WEIGHT LOSS PREDICTIVE OF THE NEED FOR RE-PLANNING OF PATIENTS WITH
HEAD AND NECK CANCER TREATED WITH IMRT? A PROSPECTIVE STUDY
Joel Broomfield, Stacey Yemchuk, Jamie Bahn, Samy El-Sayed
University of Ottawa, Ottawa, ON
244
THE RELATIONSHIP BETWEEN THE OUTCOMES OF CLINICAL STAGE III NSCLC
PATIENTS AND THE PRACTICE PATTERNS OF PHYSICIANS: A TWO PROVINCE COHORT
STUDY
1
2
1
3
3
3
Hongwei Liu , Benjamin Mou , Gerald Lim , William M Hunter , Zoann Nugent , Ethan Lyn ,
1
Harold Lau
1
2
3
Tom Baker Cancer Centre, Calgary, AB; CancareCare Manitoba, Winnipeg, MB; CancareCare
Manitoba, Winnipeg, MB
245
MAKING SMARTPHONE PROGRAMMING ACCESSIBLE TO ALL: CREATING A CANCER
STAGING APP USING APP INVENTOR FOR ANDROID SMARTPHONES
Derek S. Tsang, Pamela Catton, James D. Brierley
University of Toronto, Toronto, ON
246
HEALTH RELATED QUALITY OF LIFE IN HEAD AND NECK CANCER TREATED WITH
SURGERY WITH OR WITHOUT RADIOTHERAPY OR CHEMORADIOTHERAPY
Jonathan Livergant, Jonathan Klein, Jolie Ringash
University of Toronto, Toronto, ON
247
HEALTH RELATED QUALITY OF LIFE IN HEAD AND NECK CANCER TREATED WITH
RADIATION THERAPY WITH OR WITHOUT CHEMOTHERAPY
Jonathan Klein, Jonathan Livergant, Jolie Ringash
University of Toronto, Toronto, ON
248
CUSTOMIZED VAGINAL VAULT BRACHYTHERAPY WITH CT IMAGING-DERIVED
APPLICATOR PROTOTYPING
Ericka Wiebe, Gillian Thomas, Lisa Barbera, Harry Easton, Ananth Ravi
Odette Cancer Centre, Toronto, ON
249
THE PERCEPTION OF RADIATION THERAPY STUDENTS ON SITE-SPECIFIC TEACHING OF
A CLINICAL SPECIALIST RADIATION THERAPIST
Grace Lee, Kieng Tan, Robert Dinniwell
Princess Margaret Hospital, Toronto, ON
250
IMPLEMENTATION OF LUNG STEREOTACTIC ABLATIVE RADIOTHERAPY AT A REGIONAL
CANCER CENTRE
Ravinder Pandher, Hong-Wei Lui, Rao Khan, Mona Udowicz, Yvette Bayliss, Krista Krobutschek,
Colleen Herring, Harold Lau
University of Calgary, Calgary, AB
251
PURSUING THE METHODOLOGY TO COMPREHENSIVELY AND APPROPRIATELY
EVALUATE THE UTILITY OF EMERGING RADIATION THERAPY INNOVATIONS
Hussain Al Hussain, Libni Eapen, Jean-Michel Caudrelier
University of Ottawa, Ottawa, ON
252
NEPHRON-SPARING ROBOTIC STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) USING
CYBERKNIFE® FOR MEDICALLY INOPERABLE PRIMARY RENAL TUMOURS AND
TUMOURS ARISING FROM SOLITARY KIDNEY: REPORT OF FEASIBILITY, TECHNIQUE,
EFFICACY AND SAFETY
Vimoj Janardanan Nair, Janos Szanto, Eric Vandervoort, Ilias Cagiannos, Leonard Avruch,
Jason Pantarotto, Shawn Malone
University of Ottawa, Ottawa, ON
253
A PRACTICAL AND OBJECTIVE SCORING METHOD FOR DOSIMETRIC COMPARISON OF
INDIVIDUAL STEREOTACTIC ABLATIVE RADIOTHERAPY TREATMENT PLANS
Vimoj Janardanan Nair, Robert MacRae, Nicolas Ploquin, Brenda Clark, Jason Pantarotto
University of Ottawa, Ottawa, ON
254
ESTABLISHING A PLACE FOR AN ADVANCED PRACTICE RADIATION THERAPIST IN
PALLIATIVE RADIATION THERAPY: EXPERIENCES OF TWO URBAN CANCER CENTRES
1
2
Emily Sinclair , Michelle Lau
1
2
University of Toronto, Toronto, ON; Princess Margaret Hospital, Toronto, ON
255
ADJUVANT RADIATION THERAPY FOR METASTATIC SQUAMOUS CELL CANCER IN A
PATIENT WITH EPIDERMOLYSIS BULLOSA DYSTROPHICA: CASE STUDY AND
LITERATURE REVIEW
Theodora Koulis, Colleen Herring, Jon-Paul Voroney
Tom Baker Cancer Centre, Calgary, AB
256
EVALUATING ADJACENT ORGAN RADIATION DOSES FROM POST-OPERATIVE
INTRACAVITARY VAGINAL VAULT BRACHYTHERAPY FOR ENDOMETRIAL CANCER
1
2
1
1
1
Julianna Caon , Caroline Holloway , Rustom Dubash , Conrad Yuen , Christina Aquino-Parsons
1
2
British Columbia Cancer Agency, Vancouver, BC; British Columbia Cancer Agency, Victoria, BC
257
A PILOT STUDY USED TO COMPARE THE ACUTE SIDE EFFECTS FROM EITHER
PROSTATE BRACHYTHERAPY LDR (SEED IMPLANT) PLUS EXTERNAL BEAM
RADIOTHERAPY, OR HDR PROSTATE BRACHYTHERAPY TREATMENT PLUS EXTERNAL
BEAM RADIOTHERAPY
Tracey Rose, Eleanor Garcia, Juanita Crook
British Columbia Cancer Agency, Kelowna, BC